date,headline,source,summary
2024-10-18,Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?,Yahoo,"According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?"
2024-10-18,Abbott Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations,Yahoo,Abbott Laboratories ( NYSE:ABT ) Third Quarter 2024 Results Key Financial Results Revenue: US$10.6b (up 4.9% from 3Q...
2024-10-18,3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now,Yahoo,These stocks could deliver big over the long term.
2024-10-19,Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever,Yahoo,These companies' longtime shareholders have generally been rewarded.
2024-10-19,3 Fortune 500 Industry Leaders Boast Ideal October Dividends,SeekingAlpha,"Read an analysis of the top dividend-yielding stocks among the Fortune 500 companies of 2024, with impressive net gains and potential for growth."
2024-10-19,Abbott Laboratories (ABT): Strong Q2 Performance and Innovative Product Approvals,Yahoo,"We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best medical stocks to buy now. Navigating the Healthcare Landscape: Investment Opportunities and Growth Trends The medical and healthcare industry is one of the […]"
2024-10-21,Helping People Recover From Devastating Hurricanes,Finnhub,"News & ContentAbbottThis year's hurricane season has brought some significant, unexpected impacts - including previously unseen devastation to the mountain regions of North Carolina, Georgia and..."
2024-10-21,"Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation",SeekingAlpha,"Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices. Read why I assign a hold rating for ABT stock."
2024-10-22,"Top Research Reports for Visa, Netflix & Merck",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Netflix, Inc. (NFLX) and Merck & Co., Inc. (MRK), as well as a micro-cap stock Hovnanian Enterprises, Inc. (HOV)."
2024-10-23,"Abbott and the Big Ten Conference Tackle U.S. Blood Shortages With First-of-Its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'",Finnhub,"* To help address the greatest need for blood in a generation, Abbott, a global leader in blood testing, and the Big Ten Conference are teaming up to host the first college conference-wide blood..."
2024-10-23,"Abbott Laboratories: Promising Growth, Yet Fully Valued; A Wait-And-Watch Stock",SeekingAlpha,"Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive growth. Explore more details here."
2024-10-24,Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure,Yahoo,"Abbott (NYSE: ABT) today announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options. The TEAM-HF trial, which is planned to enroll up to 850 patients across 75 sites worldwide, will measure pulmonary artery pressures (PAP) using Abbott's CardioMEMS™ HF System to objectively identify advanced heart failure patients at high risk of mortality who could benefit from a life-saving HeartMate 3™"
2024-10-24,Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment,Yahoo,"Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don’t get fooled by that when analyzing the stock’s performance. For a dividend aristocrat, one needs to look deeper before making any conclusions. Abbott Laboratories Devices and Pharma segments offer tremendous growth opportunities, making the stock look attractive at current price […]"
2024-10-24,"Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt",Yahoo,"Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre."
2024-10-25,Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT),Yahoo,Key Insights Abbott Laboratories' estimated fair value is US$127 based on 2 Stage Free Cash Flow to Equity Abbott...
2024-10-25,"DexCom Growing Into Its Valuation, But Still No Bargain",SeekingAlpha,DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Read my DXCM earnings review.
2024-10-25,Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums,Yahoo,"MOH's third-quarter results benefit from growing membership and rising premiums, partially offset by rising expenses."
2024-10-25,Community Health Q3 Earnings Miss on Lower Adjusted Admissions,Yahoo,CYH's third-quarter earnings suffer a setback due to lower admissions and patient days. Improved occupancy levels and reimbursement rates partially offset the negatives.
2024-10-26,3 Dividend Growth Stocks You Can Buy and Hold Forever,Yahoo,These healthcare stocks have fantastic dividend track records.
2024-10-26,"HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View",Yahoo,"HCA's quarterly results benefit from improved admissions and inpatient surgeries, partially offset by the impact of hurricanes and rising salaries and benefits expenses."
2024-10-26,DexCom: Exiting The 'Expansion Phase' As Competition Intensifies,SeekingAlpha,"DexCom's stock fell sharply after mixed Q2 earnings and lowering full-year guidance, signaling a revaluation phase with lower growth expectations. Learn more on DXCM here."
2024-10-29,ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock,Yahoo,Abbott initiates the TEAM-HF trial to improve outcomes for advanced heart failure.
2024-10-29,My Best Dividend Aristocrats For November 2024,SeekingAlpha,"NOBL ETF went on a great run during Q3, gaining 11.6% during the quarter. Find out the best dividend aristocrat picks for November 2024."
2024-10-29,Abbott Laboratories stock outperforms competitors despite losses on the day,MarketWatch,Abbott Laboratories stock outperforms competitors despite losses on the day
2024-10-30,New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management,Yahoo,"Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, revealing key motivators to help them manage their condition."
2024-10-30,Abbott's FreeStyle Libre® 2 and 3: First Continuous Glucose Monitoring Systems Approved for Use During Medical Imaging,Finnhub,Abbott's world-leading1 FreeStyle Libre 2 and 3 systems for people living with diabetes are now the only continuous glucose monitoring sensors 2 in the U.S. that users do not need to remove during...
2024-10-31,Abbott Laboratories stock underperforms Thursday when compared to competitors,MarketWatch,Abbott Laboratories stock underperforms Thursday when compared to competitors
2024-11-01,Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial,Yahoo,Abbott stock surged early Friday after a jury decided baby formula from Abbott and Mead Johnson are not responsible for a boy's disease.
2024-11-01,"Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case",Yahoo,The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
2024-11-01,"Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win",Yahoo,"Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a Missouri jury cleared the two infant formula makers of liability for a boy's debilitating intestinal disease."
2024-11-01,"Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win",Yahoo,"Shares of Abbott Laboratories and Reckitt Benckiser rose after the companies won a victory in litigation over the safety of some baby-formula products.  Abbott shares rose 4% in early New York trading, while Reckitt’s shares were up 8% in London.  A jury in Missouri state court found Reckitt’s Mead Johnson unit and Abbott weren't liable for injuries suffered by a boy who consumed their formulas designed for premature babies, following a civil trial."
2024-11-01,Abbott shares rise after securing first win in premature infant formula trial,Yahoo,"A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's severe intestinal disease, marking the first victory for the companies after large losses in two previous trials.  The lawsuit was one of about 1,000 similar cases pending nationwide over allegations the companies failed to warn that their specialized formulas used by newborn intensive care units in hospitals could cause necrotizing enterocolitis (NEC).  NEC almost exclusively affects premature infants and has an estimated mortality rate of more than 20%."
2024-11-01,Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up,Yahoo,"If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see..."
2024-11-01,"Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win",Yahoo,Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
2024-11-01,"Reckitt, Abbott surge after winning an NEC case",Yahoo,"Investing.com -- A jury ruled on Thursday that Abbott Laboratories (NYSE:ABT) and Mead Johnson, a division of Reckitt Benckiser (LON:RKT), are not liable for a young boy's severe intestinal disease, marking a significant win for the companies after substantial losses in similar cases."
2024-11-01,Wall Street Breakfast Podcast: Boeing Aims To Land Union Deal...Again,SeekingAlpha,"Boeing reaches deal to end machinist strike. Aurora to delay commercial launch of driverless truck. Abbott jumps as jury says company, Reckitt not liable in infant formula case."
2024-11-01,Health Care Up on Defensive Demand -- Health Care Roundup,MarketWatch,Health Care Up on Defensive Demand -- Health Care Roundup
2024-11-01,Abbott Laboratories stock outperforms competitors on strong trading day,MarketWatch,Abbott Laboratories stock outperforms competitors on strong trading day
2024-11-01,Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight,Yahoo,Insightful Analysis of Abbott Laboratories' Market Position and Future Prospects
2024-11-01,"Premarket movers: Amazon, Apple, Intel",MarketWatch,"Premarket movers: Amazon, Apple, Intel"
2024-11-01,Abbott Laboratories Shares Rise After Baby-Formula Verdict,Finnhub,"By Connor Hart A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged..."
2024-11-01,Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling,MarketWatch,Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling
2024-11-02,"Abbott, Reckitt found not liable in baby formula case. Stocks rise.",Yahoo,"A Missouri jury found Abbott Laboratories (ABT) and a unit of Reckitt Benckiser (RBGLY) not responsible for an infant death originally claimed to be tied to the company's baby formulas. The two health companies are seeing their shares rise on Friday following this legal victory. Market Domination's Julie Hyman and Josh Lipton report more on the story. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan."
2024-11-04,Abbott Laboratories : Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit™ BTK System for People Battling Peripheral Artery Disease Below the Knee,Finnhub,Two-year LIFE BTK data demonstrates sustained safety and efficacy of Abbott's Esprit BTK Everolimus Eluting Resorbable Scaffold System in treating peripheral artery disease below the knee ...
2024-11-05,"Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution",Yahoo,"In the last year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a substantial stake in the company which may have..."
2024-11-05,Abbott price target raised to $149 from $143 at Barclays,Yahoo,"Barclays analyst Matt Miksic raised the firm’s price target on Abbott (ABT) to $149 from $143 and keeps an Overweight rating on the shares. The firm now expects Abbott’s share of the necrotizing enterocolitis liability to be closer to the low end of the expected range, or $1B-$3B. The company’s earnings growth, excluding a 5c-10c per year contribution from COVID, is projected to grow 11% growth between in 2024 and 2026, the analyst tells investors in a research note. Published first on TheFly –"
2024-11-05,"Abbott Laboratories stock rises Tuesday, still underperforms market",MarketWatch,"Abbott Laboratories stock rises Tuesday, still underperforms market"
2024-11-05,Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now?,Yahoo,"We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other pharma stocks. Healthcare takes the concept of ‘defensive’ further than almost any industry, encompassing many companies that provide patient care, engage in […]"
2024-11-07,"Abbott Laboratories (ABT) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era",Yahoo,"We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take a look at where Abbott Laboratories (NYSE:ABT) ranks on the list of the top UBS AI and growth era. The stock market at the tail end of 2024 […]"
2024-11-07,Abbott Laboratories stock underperforms Wednesday when compared to competitors,MarketWatch,Abbott Laboratories stock underperforms Wednesday when compared to competitors
2024-11-08,"If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?",Yahoo,"Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops, manufactures and sells health care products worldwide. It is set to report its Q4 2024 earnings on Jan. 22, 2025. Wall Street analysts expect the company to post an ..."
2024-11-08,"The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE",Yahoo,"Amazon.com, Procter & Gamble, Abbott and NVE are part of the Zacks top Analyst Blog."
2024-11-08,Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever,Yahoo,You'll also like these stocks for their track record of earnings growth.
2024-11-08,UK regulator flags concerns and remedies for sale of baby formula,Finnhub,"Britain's competition watchdog flagged concerns and potential solutions regarding the distribution of infant formulas on Friday, which could help improve the sector as well as manage costs for..."
2024-11-08,"Top Stock Reports for Amazon.com, Procter & Gamble & Abbott",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & Gamble Co. (PG) and Abbott Laboratories (ABT), as well as a micro-cap stock NVE Corp. (NVEC)."
2024-11-09,Is Abbott Laboratories' (NYSE:ABT) Recent Stock Performance Influenced By Its Financials In Any Way?,Yahoo,Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 7.2% over the past three...
2024-11-09,"Dividend Champion, Contender, And Challenger Highlights: Week Of November 10",SeekingAlpha,"Stay up to date on dividend activity with our weekly summary for Dividend Champions, Contenders, and Challengers, including ex-dividend and pay dates."
2024-11-13,US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024,Yahoo,The TTVR market has witnessed significant growth of 56% in the US in 2024's third quarter.
2024-11-13,Abbott Laboratories (NYSE:ABT) shareholders have earned a 8.6% CAGR over the last five years,Yahoo,"When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore..."
2024-11-14,3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years,Yahoo,These are income stocks you can buy and hold forever.
2024-11-14,Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2024 Update,SeekingAlpha,GMOâs 13F portfolio increased to $31.91B in Q3 2024. Click here to read more about the holdings and trades of GMO Capital Portfolio.
2024-11-16,Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains,MarketWatch,Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains
2024-11-17,Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now,Yahoo,"We recently compiled a list of the 8 Magnificent Dividend Growth Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other magnificent dividend growth stocks. This year, dividend stocks have underperformed compared to the broader market, largely because tech stocks have captured most […]"
2024-11-18,Abbott Laboratories : Late Breaking Data Reinforce Long Term Benefits of Abbott's Amplatzer™ Amulet™ Device for People With Atrial Fibrillation at Risk of Stroke,Finnhub,New five-year outcomes presented at American Heart Association's Scientific Sessions show that Amplatzer Amulet helps more patients avoid long-term use of blood-thinning medication compared to...
2024-11-18,Inside a $400 billion bet on the brain-computer interface revolution,Yahoo,Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.
2024-11-19,DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring,MarketWatch,DexCom Pairs Its Glucose Monitor With Oura’s Smart Ring
2024-11-19,Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?,Yahoo,"Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?"
2024-11-19,How I Repurposed My Late Father's Trust Account,SeekingAlpha,I restructured my father's Trust for better diversification and risk reduction. See why I reduced Health Care and Consumer stocks and shifted to new sectors.
2024-11-19,IXJ: Healthcare Sector Dashboard For November,SeekingAlpha,"November dashboard shows the healthcare sector is overvalued by 18% relative to 11-yr averages; pharma/biotech and healthcare equipment, the most overpriced."
2024-11-21,Major companies that are also popular short-selling stocks,Yahoo,"Investor confidence in certain major companies has propelled markets higher, but there are also those betting against big-name stocks through short selling."
2024-11-22,Abbott Laboratories stock underperforms Thursday when compared to competitors despite daily gains,MarketWatch,Abbott Laboratories stock underperforms Thursday when compared to competitors despite daily gains
2024-11-23,2 Dividend Kings to Buy for a Lifetime of Passive Income,Yahoo,Dividend Kings are among the best income stocks on the market.  Let's consider two companies in this elite group with the exact qualities long-term income investors want: Coca-Cola (NYSE: KO) and Abbott Laboratories (NYSE: ABT).  Few businesses are better known worldwide than Coca-Cola.
2024-11-24,Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company,Yahoo,Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...
2024-11-25,Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis,Yahoo,Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic stenosis. This investigational Abbott TAVI system is the first step toward Abbott's software-guided balloon-expandable TAVI system and is designed to build a foundation for artificial intelligence (AI) guided procedures. Once the investigational balloon-expandable system completes clinical developm
2024-11-25,Abbott Laboratories: Investors Should Wait For A Pullback,SeekingAlpha,Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need to be patient with ABT stock.
2024-11-26,InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors,Yahoo,"MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors. Mr. Ward most recently served as Chief Executive Officer and President of Cardiovascular Systems, Inc. prior to its acquisition by Abbott (NYSE: ABT) in April 2023. Paul Stuka, Chairman of the Board of InspireMD, sta"
2024-11-26,Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains,MarketWatch,Abbott Laboratories stock underperforms Monday when compared to competitors despite daily gains
2024-11-28,"Top Research Reports for Abbott, BlackRock & ConocoPhillips",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BlackRock, Inc. (BLK) and ConocoPhillips (COP), as well as two micro-cap stocks, NetSol Technologies, Inc. (NTWK) and Optex Systems Holdings, Inc (OPXS)."
2024-11-29,Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues,Yahoo,Abbott has a unique opportunity to scale a capital-efficient licensing model that can help the emerging market population access life-changing medicines.
2024-11-29,Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT),Yahoo,Key Insights The projected fair value for Abbott Laboratories is US$137 based on 2 Stage Free Cash Flow to Equity...
2024-11-29,"The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems",Yahoo,"Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems are included in this Analyst Blog."
2024-11-30,The Dividend Aristocrats Ranked By Quality Scores: November 2024,SeekingAlpha,"Financial writer ranks S&P 500 Dividend Aristocrats by quality scores, categorizes undervalued/overvalued stocks, provides detailed analysis for informed..."
2024-11-30,Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $118.77, denoting a -0.15% change from the preceding trading day."
2024-12-02,Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025,SeekingAlpha,Stereotaxis' holistic ecosystem approach aims to solve long-standing issues with robotic adoption in EP. See why STXS stock is a Buy.
2024-12-02,"Mastercard, Broadcom, Pfizer Among Two Dozen Companies To Announce Dividend Increases In December",SeekingAlpha,"Itâll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the companies with dividend increases."
2024-12-03,Abbott Laboratories stock underperforms Monday when compared to competitors,MarketWatch,Abbott Laboratories stock underperforms Monday when compared to competitors
2024-12-05,Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet,Yahoo,"The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?"
2024-12-05,Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up,Yahoo,"If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common..."
2024-12-06,Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note,Yahoo,"In the latest trading session, Abbott (ABT) closed at $115.59, marking a -0.33% move from the previous day."
2024-12-07,Oracle And Broadcom Are Top Names Reporting Results As Earning Season Winds Down,SeekingAlpha,Stay informed on key market events with Seeking Alpha's Wall Street Week Ahead.
2024-12-07,"Abbott Laboratories stock rises Friday, still underperforms market",MarketWatch,"Abbott Laboratories stock rises Friday, still underperforms market"
2024-12-08,"University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott",Finnhub,"Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide competition this college football season, helping save as many as 60,000..."
2024-12-08,"University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott",Yahoo,"This college football season, Abbott (NYSE: ABT) and the Big Ten put fandom and the hearts of Big Ten communities to the test with their inaugural blood donation competition, ""The We Give Blood Drive."""
2024-12-09,"Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness",Yahoo,"Over the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which may..."
2024-12-09,"University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide We Give Blood Drive Competition, Receives $1 Million Grant from Abbott",Finnhub,"ABBOTT PARK, INDIANAPOLIS - This college football season, Abbott and the Big Ten put fandom and the hearts of Big Ten communities to the test with their inaugural blood donation competition, 'The We..."
2024-12-10,Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth?,Yahoo,"We recently compiled a list of the 8 Best Dividend Kings To Invest In For Safe Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other dividend kings. Investors often focus on stock price movements, anticipating gains, but may underestimate the value of dividends as […]"
2024-12-12,On Ozempic? Big Food Makers Have a New Label for You,Yahoo,Conagra Brands is adding “GLP-1 friendly” to packaging on Healthy Choice frozen meals to woo users of weight-loss drugs.
2024-12-12,"Market Mania Won’t Last. Buy These Stocks to Weather the Storm, Analyst Says.",MarketWatch,"Market Mania Won’t Last. Buy These Stocks to Weather the Storm, Analyst Says."
2024-12-12,Abbott (ABT) Stock Sinks As Market Gains: Here's Why,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $114.14, denoting a -1.18% change from the preceding trading day."
2024-12-13,Abbott Increases Quarterly Dividend for 53rd Consecutive Year,Yahoo,"Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 59 cents per share, an increase of 7.3%. The company's quarterly dividend payout has increased more than 60% since 2020."
2024-12-13,Abbott Labs Extends Royal Dividend Run With 7.3% Increase,Finnhub,"By Colin Kellaher Abbott Laboratories' board has raised the quarterly dividend by 7.3%, to 59 cents, making it 53 straight years that the healthcare-products company has boosted its payout. ..."
2024-12-14,"Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",SeekingAlpha,Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.
2024-12-14,"Dividend Champion, Contender, And Challenger Highlights: Week Of December 15",SeekingAlpha,"Stay updated on dividend activity for top companies, including changes in dividends and upcoming ex-dividend and pay dates."
2024-12-14,"Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns",Yahoo,"Abbott boosts dividends and highlights steady growth, reflecting strong shareholder return policies and financial health."
2024-12-14,PBH or ABT: Which Is the Better Value Stock Right Now?,Yahoo,PBH vs. ABT: Which Stock Is the Better Value Option?
2024-12-14,Abbott Laboratories stock underperforms Friday when compared to competitors,MarketWatch,Abbott Laboratories stock underperforms Friday when compared to competitors
2024-12-16,Abbott Increases Quarterly Dividend for 53rd Consecutive Year,Finnhub,"ABBOTT PARK - Abbott today announced that its board of directors has increased the company's quarterly common dividend to 59 cents per share, an increase of 7.3%.The company's quarterly dividend..."
2024-12-17,Are Abbott Laboratories' (NYSE:ABT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?,Yahoo,"It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has..."
2024-12-17,Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart,Yahoo,"Abbott (NYSE: ABT) today announced the successful completion of the world's first in-human leadless left bundle branch area pacing (LBBAP) procedures using the company's investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system, as part of a feasibility study. These procedures mark the first time a leadless pacemaker has been implanted into the left bundle branch area, a key part of the heart's electrical conduction system, designed to mimic the heart's natural beat, offeri"
2024-12-17,Mairs & Power Balanced Fund Q3 2024 Commentary,SeekingAlpha,The Mairs & Power Balanced Fund finished the first nine months of 2024 up 11.02%. Click here to read the full commentary. 
2024-12-18,ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker,Yahoo,Abbott completes the world's first leadless pacing procedures in the left bundle branch of the heart.
2024-12-18,The Smartest Dividend Stocks to Buy With $500 Right Now,Yahoo,"If you add a few dividend stocks to your portfolio, you'll start collecting returns on a regular basis -- without lifting a finger.  Loads of companies pay dividends, so it might seem difficult make a selection.  A great way to start is to consider the list of Dividend Kings, companies that have increased their dividend payments for at least 50 consecutive years."
2024-12-18,Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know,Yahoo,"In the latest trading session, Abbott (ABT) closed at $113.29, marking a +0.59% move from the previous day."
2024-12-18,Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta,Yahoo,Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2* flash glucose monitoring system to the Alberta Drug Benefit List.
2024-12-18,Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains,MarketWatch,Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains
2024-12-19,4 Healthcare Technology Innovators to Invest in Before the New Year,Yahoo,"Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT."
2024-12-19,Reasons to Retain ABT Stock in Your Portfolio Now,Yahoo,"Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning."
2024-12-19,2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond,Yahoo,"Whatever the answer is, it probably won't be dividend investing.  Let's consider two income-focused corporations whose shares are worth holding on to well beyond next year: AbbVie (NYSE: ABBV) and Abbott Laboratories (NYSE: ABT).  AbbVie, a former division of Abbott Laboratories, became a stand-alone company in 2013."
2024-12-20,"The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories",Yahoo,"Veracyte, Omnicell, Masimo and Abbott Laboratories are included in this Analyst Blog."
2024-12-22,Abbott Laboratories' (NYSE:ABT) investors will be pleased with their respectable 43% return over the last five years,Yahoo,"The main point of investing for the long term is to make money. But more than that, you probably want to see it rise..."
2024-12-24,Wall Street Breakfast Podcast: Biden To Rule On US Steel Takeover,SeekingAlpha,Biden to decide on US Steel takeover after CFIUS deadlocks. Rocket Companies stock drops after CFPB sues Rocket Mortgages. Abbott in settlement with DexCom over continuous glucose monitors.
2024-12-24,Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing,Yahoo,"The latest trading day saw Abbott (ABT) settling at $114.31, representing a +0.07% change from its previous close."
2024-12-24,Ensign Expands Footprint With Buyout of Eight Healthcare Facilities,Yahoo,"ENSG agrees to buy eight healthcare facilities from Providence Home and Community Care, expanding its footprint."
2024-12-24,"DexCom, Abbott Agree to Settlement in Patent Litigation",DowJones,"DexCom, Abbott Agree to Settlement in Patent Litigation"
2024-12-24,"Abbott Laboratories stock rises Monday, still underperforms market",MarketWatch,"Abbott Laboratories stock rises Monday, still underperforms market"
2024-12-25,"Abbott, DexCom settlement ‘not a complete surprise,’ says Wells Fargo",Yahoo,"Wells Fargo notes Abbott (ABT) and DexCom (DXCM) have disclosed that on December 20, they settled and entered into a cross-license agreement to resolve all outstanding patent litigation in the U.S. and Europe for 10 years. Under the agreement, both companies granted each other worldwide royalty-free, nonexclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the litigation. The firm had expected the parties"
2024-12-25,"DexCom, Abbott agree to settle patent litigation",Yahoo,"In a regulatory filing, DexCom (DXCM) stated: “As previously disclosed, DexCom has been involved in global patent litigation with Abbott (ABT) Diabetes Care and its affiliates. Both the Company and Abbott have accused the other of infringing certain patents, and each party has filed counterclaims and actions to invalidate the other party’s patents. On December 20, the Company and Abbott entered into a settlement and patent cross license agreement to resolve all outstanding patent litigation betw"
2024-12-25,Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note,Yahoo,"Abbott (ABT) closed the most recent trading day at $114.76, moving +0.39% from the previous trading session."
2024-12-25,Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA,Yahoo,GKOS announces New Drug Application submission for its Epioxa to the FDA.
2024-12-27,"Growing Biosimilars Business, New Partnerships Support ABT Stock",Yahoo,"Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre."
2024-12-27,Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 77% of the company,Yahoo,Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...
2024-12-27,Is Abbott Stock Worth Buying at a Discounted P/S Valuation?,Yahoo,"Abbott's strong market position, promising growth prospects and consistent share gains make it a compelling pick for investors."
2024-12-28,Why Is Abbott Laboratories (ABT) Among Diamond Hill Capital’s Top Stock Picks?,Yahoo,"We recently compiled a list of the Diamond Hill Capital’s Top 10 Stock Picks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against Diamond Hill Capital’s other stock picks. Heather Brilliant’s Diamond Hill Capital is a Columbus, Ohio-based investment management firm founded in 1997 by Ric Dillon, who managed […]"
2024-12-28,"2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",Yahoo,"In any case, it should have a solid track record of earnings growth and promising long-term prospects.  Second, after spending more than $1 million on a robot, hospitals will probably continue using the platform, aiming to amortize the investment over a period of years."
2024-12-30,5 MedTech Stocks That Are Poised to Beat the Market in 2025,Yahoo,"Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices."
2024-12-30,"My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks",SeekingAlpha,Learn how the power of dividend growth investing and how commitment and a long-term mindset can help you reach your financial goals in this article. Click for more.
2024-12-30,Highest Quality Dividend Kings For 2025,SeekingAlpha,Only 11 Dividend Kings outperformed the S&P 500 during the last decade based on Total Return. Check out five Dividend Kings earn the rank of High Quality.
2024-12-31,A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT),Yahoo,"Key Insights Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$138 With US$113..."
2024-12-31,Boston Scientific Corporation: Solid Financials And Upward Continuation,SeekingAlpha,"Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. Check out why I rate BSX stock a buy now."
2024-12-31,Abbott (ABT) Dips More Than Broader Market: What You Should Know,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $112.80, denoting a -1.9% change from the preceding trading day."
2024-12-31,"Chevron, Kimberly-Clark Among 15 Companies To Announce Dividend Increases In January",SeekingAlpha,"Get the scoop on upcoming dividend increases from companies with long-term growth histories, including modest increases from Chevron and Kimberly-Clark in..."
2025-01-02,Abbott Hosts Conference Call for Fourth-Quarter Earnings,Yahoo,"Abbott (NYSE: ABT) will announce its fourth-quarter 2024 financial results on Wednesday, Jan. 22, before the market opens."
2025-01-02,3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years,Yahoo,"Here's a list of stocks that have been raising their dividend payments consistently for more than 50 consecutive years.  Combined, they add up to 165 years' worth of increases.  Three of the best dividend stocks you can buy and hold today are Target (NYSE: TGT), Hormel Foods (NYSE: HRL), and Abbott Laboratories (NYSE: ABT)."
2025-01-02,Jim Cramer’s Take on Abbott Laboratories (ABT): Bold Predictions for the Future,Yahoo,"We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim Cramer’s favorite topics lately. The […]"
2025-01-03,Are Medical Stocks Lagging  Abbott Laboratories (ABT) This Year?,Yahoo,"Here is how Abbott (ABT) and Acurx Pharmaceuticals, Inc. (ACXP) have performed compared to their sector so far this year."
2025-01-04,Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt,Yahoo,"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of..."
2025-01-06,Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy?,Yahoo,"We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other January dividend stocks. In 2024, dividend stocks fell short of investor expectations, largely due to the continuing AI boom and a heightened interest […]"
2025-01-07,Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know,Yahoo,"In the latest trading session, Abbott (ABT) closed at $113.04, marking a -0.69% move from the previous day."
2025-01-08,Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?,Yahoo,"ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology and Consumer Diagnostics."
2025-01-08,BDSX Stock Rises After Publication of Study Data for Nodify CDT Test,Yahoo,Biodesix announces positive study data for its Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal.
2025-01-08,CURE: Analyst Estimates Point To Significant Gains In 2025,SeekingAlpha,The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks.
2025-01-08,Abbott Laboratories Q4 2024 Earnings Preview,SeekingAlpha,"Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I maintain my buy rating on ABT stock."
2025-01-08,Here's Why You Should Retain BDX Stock in Your Portfolio for Now,Yahoo,"BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns."
2025-01-09,"AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines",Yahoo,"ANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business."
2025-01-11,"First Earnings Season For 2025 Kicks Off With Big Banks, Inflation Data",SeekingAlpha,Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter.
2025-01-11,"Dividend Champion, Contender, And Challenger Highlights: Week Of January 12",SeekingAlpha,"Stay updated on dividend activity for companies in the Champions, Contenders, and Challengers categories, as well as upcoming ex-dividend and pay dates."
2025-01-14,Boston Scientific Standing Apart As A Rare Med-Tech Growth Story,SeekingAlpha,Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn more about BSX stock here.
2025-01-14,AbbVie Has Immense Cash Flow Potential,SeekingAlpha,"AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations. Read more about ABBV stock here."
2025-01-15,How To Write A Case Brief: The Ultimate Cheatsheet,Finnhub,"Case briefing has a long history in legal studies as a tried-and-true method for reviewing and analyzing judicial opinions.Whether you're a law student attempting to master case briefing, or a lawyer..."
2025-01-15,Abbott Laboratories stock underperforms Tuesday when compared to competitors,MarketWatch,Abbott Laboratories stock underperforms Tuesday when compared to competitors
2025-01-16,‘Wolf Man’ Review: Christopher Abbott’s Feral Father,DowJones,‘Wolf Man’ Review: Christopher Abbott’s Feral Father
2025-01-16,AIVL: This AI-Powered ETF Still Has To Prove Itself,SeekingAlpha,"WisdomTree U.S. AI Enhanced Value Fund (AIVL) is a new ETF targeting value stocks with AI model, but lags S&P Mid-Cap 400 Index. Read a review here."
2025-01-18,"Netflix, Procter & Gamble, Johnson & Johnson Report Results In Holiday-Shortened Week",SeekingAlpha,Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter.
2025-01-19,The Week Ahead,SeekingAlpha,"Get ready for a busy week on Wall Street! Earnings reports from big names like Netflix, Procter & Gamble, and Johnson & Johnson are on the horizon."
2025-01-19,Wall Street Week Ahead,SeekingAlpha,Stay informed with the latest financial news on Wall Street Breakfast.
2025-01-19,"Senseonics Holdings' Metrics Potentially Highlight Launch-Driven Growth, Not Sustainability",SeekingAlpha,Senseonics' stock is largely unchanged versus S&P 500 gains of 31% since my sell recommendation in August 2023. See why I rate SENS stock a strong sell.
2025-01-20,"Becton, Dickinson: Hold, Momentum Is Gaining, Just Need More Growth",SeekingAlpha,"Financial writer rates Becton Dickinson and Co as a hold due to low growth and valuation concerns, despite positive indicators for future growth."
2025-01-20,IYH: Healthcare Dashboard For January,SeekingAlpha,iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.
2025-01-22,"Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall",Yahoo,"On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying base business was 8.8%. Organic growth, excluding COVID-19 testing-related sales was 10.1%. Adjusted diluted earnings per share were $1.34, in line with the analyst estimates and management consensus of $1.31-$1.37, up from $1.19 a year ago. Also Read: FDA Bans Red Dye No. 3 Effective January 2027, C"
2025-01-22,"Compared to Estimates, Abbott (ABT) Q4 Earnings: A Look at Key Metrics",Yahoo,"The headline numbers for Abbott (ABT) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals."
2025-01-22,Correction to Abbott Labs 4Q Sales Just Miss Estimates Article,Finnhub,"Abbott Labs on Wednesday reported net earnings of $9.23 billion, or $5.27 a share, for the three months ended Dec. 31, up from $1.59 billion, or $1.91 cents a share, a year earlier. Abbott Labs 4Q..."
2025-01-22,Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update,MarketWatch,Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update
2025-01-22,Abbott (ABT) Q4 Earnings Meet Estimates,Yahoo,"Abbott (ABT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?"
2025-01-22,Abbott: Q4 Earnings Snapshot,Yahoo,"The average estimate of nine analysts surveyed by Zacks Investment Research was also for earnings of $1.34 per share. The maker of infant formula, medical devices and drugs posted revenue of $10.97 billion in the period, missing Street forecasts. Eight analysts surveyed by Zacks expected $11.02 billion."
2025-01-22,"Abbott banks on glucose monitors, new launches to ride out China, currency hit",Yahoo,"Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a hit from weakness in China and a stronger dollar.  The company, which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor.  Abbott had been facing supply issues for its Libre devices and said it will meet the demand mismatch as it gets one of its manufacturing sites up and running."
2025-01-22,Abbott Labs: Annual EPS in line with expectations,Finnhub,"Abbott Laboratories reports fourth-quarter 2024 adjusted EPS in line with expectations at $1.34, bringing the year-to-date figure to $4.67, in line with its target range of three months ago .The..."
2025-01-22,Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales,Finnhub,"By Denny Jacob Abbott Laboratories posted lower-than-expected sales in its latest quarter, dented in part by diminished demand for Covid-19 testing-related products. The healthcare-products..."
2025-01-22,Abbott forecasts in line annual profit on medical device sales,Finnhub,"Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated medtech-related procedures to boost demand for its devices, including..."
2025-01-22,Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook,Finnhub,Fourth-quarter sales of $11.0 billion; full-year 2024 sales of $42.0 billionFourth-quarter reported sales increased 7.2 percent; organic sales growth for the underlying base business increased 10.1...
2025-01-23,"Abbott reports Q4 adjusted EPS $1.34, consensus $1.34",Yahoo,"Reports Q4 revenue $11B, consensus $11.03B. “We finished the year with very strong momentum. Sales growth and earnings per share growth in the fourth quarter were the highest of the year,” said Robert B. Ford, chairman and chief executive officer, Abbott (ABT). “We continued our track record for delivering on our commitments by achieving the upper end of our initial guidance ranges for 2024 and are well-positioned to deliver another year of strong growth in 2025.” Published first on TheFly – the"
2025-01-23,My Top 5 Stocks to Buy in Early 2025,Yahoo,"It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in 2025 and over the long term.  The healthcare space is a great place to look for these sorts of players because here you'll find all that you need to gain in both growth and security -- from young biotechs developing game-changing technologies to big pharma or medical device players selling blockbuster drugs and paying out dividends to investors.  If you select quality companies and diversify across these themes of growth and security, your portfolio could shine during any market environment -- and, most importantly, offer you solid returns over the long term."
2025-01-23,Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade),SeekingAlpha,Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.
2025-01-23,Abbott Laboratories (ABT) Q4 2024 Earnings Call Highlights: Strong Growth Across Key Segments ...,Yahoo,"Abbott Laboratories (ABT) reports robust sales growth and improved margins, setting the stage for continued success in 2025 despite market challenges."
2025-01-23,Q4 2024 Abbott Laboratories Earnings Call,Yahoo,Q4 2024 Abbott Laboratories Earnings Call
2025-01-23,"Abbott Reports Fourth-Quarter and Full-Year 2024 Results, Issues 2025 Financial Outlook",Finnhub,"ABBOTT PARK - Abbott today announced financial results for the fourth quarter ended Dec. 31, 2024.Fourth-quarter sales increased 7.2 percent on a reported basis, 8.8 percent on an organic basis, and..."
2025-01-23,"Abbott Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine",Yahoo,Abbott stock reversed early losses Wednesday on its strong sales outlook for 2025 and a bullish performance from its diabetes devices.
2025-01-23,"Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market",Yahoo,ABT delivers a strong underlying base business performance for the fourth quarter of 2024.
2025-01-23,Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript,Yahoo,"ABT earnings call for the period ending December 31, 2024."
2025-01-23,Health Care Down on Mixed Earnings -- Health Care Roundup,Finnhub,"Health-care companies ticked down amid mixed earnings. Johnson & Johnson fell even after it unveiled financial results that beat Wall Street expectations, as investors brace for one of its..."
2025-01-23,Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings.,Yahoo,"Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street estimates of $11.03 billion."
2025-01-23,Abbott Labs misses Q4 sales estimates,Yahoo,"Abbott Laboratories (ABT) reported weaker-than-expected fourth quarter sales due to weakness in its nutrition and diagnostics units. The company's full-year outlook met estimates as medical device demand is expected to continue to grow. Catalysts Hosts Seana Smith and Madison Mills discuss the company's medical device sales, which saw double-digit gains in the quarter. To watch more expert insights and analysis on the latest market action, check out more Catalysts here."
2025-01-23,Here's Why You Should Retain PacBio Stock in Your Portfolio for Now,Yahoo,PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
2025-01-23,GEHC Stock Gains on the Collaborated Launch of Care Innovation Hub,Yahoo,"GE HealthCare announces the launch of a Care Innovation Hub, a joint research collaboration with the University of California, San Francisco."
2025-01-23,Is Abbott Laboratories (ABT) Expected to Post Impressive Earnings This Week?,Yahoo,"We recently published a list of 10 Stocks Expected To Post Impressive Earnings This Week. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks expected to post impressive earnings this week. The earnings season is in full flow as we kick off the week with […]"
2025-01-23,Abbott Fourth-Quarter Revenue Misses Views; Healthcare Firm Sees 2025 Organic Acceleration,Yahoo,Abbott Laboratories (ABT) reported slightly slower-than-expected fourth-quarter revenue growth on We
2025-01-24,BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech,Yahoo,"BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery."
2025-01-24,What Can The Dividend Kings Deliver In 2025?,SeekingAlpha,The Dividend Kings underperformed in 2024. Read here to know about the top 18 most opportune Dividend Kings based on valuation and total return.
2025-01-25,"Top Stock Reports for Cisco, Abbott & Coca-Cola",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), Abbott Laboratories (ABT) and The Coca-Cola Company (KO)."
2025-01-26,Abbott Laboratories: Strong Q4 Results And Bullish Outlook,SeekingAlpha,"Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS increase."
2025-01-27,"Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?",SeekingAlpha,Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term growth potential despite high valuations.
2025-01-29,My Best Dividend Aristocrats For February 2025,SeekingAlpha,Read here for an update on 3 strategies to potentially beat the ProShares S&P 500 Dividend Aristocrat ETF in the long term with higher dividend yields.
2025-02-01,"Musk’s X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit",DowJones,"Musk’s X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit"
2025-02-04,Communications Services Up as Traders Chase Gain - Communications Services Roundup,MarketWatch,Communications Services Up as Traders Chase Gain - Communications Services Roundup
2025-02-07,"Our Real-Life Market-Beating U.S. Stock Portfolio, Ten Years After",SeekingAlpha,"Discover the successful decade-long journey of a stock portfolio focusing on dividend growth companies, outperforming the S&P 500. Find out the lessons I've learned."
2025-02-08,"Dividend Champion, Contender, And Challenger Highlights: Week Of February 9",SeekingAlpha,Stay informed on the latest dividend activity for top companies with this weekly summary. Read more here.
2025-02-08,Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility,DowJones,Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility
2025-02-13,Janus Henderson Global Life Sciences Fund Q4 2024 Commentary,SeekingAlpha,The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click here to read the full commentary. 
2025-02-14,AbbVie Names CEO Robert Michael Chairman as Richard Gonzalez Retires,MarketWatch,AbbVie Names CEO Robert Michael Chairman as Richard Gonzalez Retires
2025-02-14,Tracking Jeremy Grantham's GMO Capital Portfolio - Q4 2024 Update,SeekingAlpha,GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value assets. See more here.
2025-02-14,Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary,SeekingAlpha,The Portfolio returned -10.75% (gross) and the MSCI World Health Care IndexSM returned -11.32%. Read more here.
2025-02-16,IXJ: Healthcare Sector Dashboard For February,SeekingAlpha,The healthcare sector is currently overvalued by about 13% relative to 11-year averages. Check out the top-down analysis of the healthcare sector.
2025-02-20,Abbott Laboratories stock underperforms Wednesday when compared to competitors despite daily gains,MarketWatch,Abbott Laboratories stock underperforms Wednesday when compared to competitors despite daily gains
2025-02-21,Abbott Declares 405th Consecutive Quarterly Dividend,Finnhub,"ABBOTT PARK, Ill., Feb. 21, 2025 /PRNewswire/ -- The board of directors of Abbott today declared a quarterly common dividend of 59 cents per share.This marks the 405th consecutive quarterly..."
2025-02-24,Abbott Declares 405th Consecutive Quarterly Dividend,Finnhub,"ABBOTT PARK, Ill. - The board of directors of Abbott today declared a quarterly common dividend of 59 cents per share.This marks the 405th consecutive quarterly dividend to be paid by Abbott since..."
2025-02-27,My Best Dividend Aristocrats For March 2025,SeekingAlpha,Discover 3 strategies outperforming the Dividend Aristocrat Index with higher yields and superior CAGR. Start 2025 with smarter investing insights.
2025-02-27,Dividend Stocks Are Dangerous. Where to Find Safety and Yield Now.,MarketWatch,Dividend Stocks Are Dangerous. Where to Find Safety and Yield Now.
2025-02-27,2025 Dividend Kings - Off To A Strong Start,SeekingAlpha,"The Dividend Kings are outperforming the S&P 500 in 2025, up 4% YTD versus 1.39% for SPY. Check out the list of dividend kings that are attractive."
2025-03-05,The Dividend Aristocrats Ranked By Quality Scores: March 2025,SeekingAlpha,S&P Dow Jones Indices added three new members to the S&P 500 Dividend Aristocrats Index. Click here to find out my ranking of dividend aristocrats.
2025-03-05,"Healthcare Stocks Fall, Led Lower by Suppliers - Healthcare Roundup",Finnhub,"Healthcare shares' performance Tuesday hinged on their exposure to trade. Tariff news slammed healthcare companies that depend on trade. Suppliers such as Becton, Dickinson and Abbott Laboratories..."
2025-03-06,Abbott (ABT) Gains But Lags Market: What You Should Know,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $137.71, denoting a +0.09% change from the preceding trading day."
2025-03-07,2 Dependable Dividend Stocks That Can Pay You for Life,Yahoo,"What makes an outstanding dividend stock?  High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how juicy its dividend yield.  For those seeking dividend stocks to buy and hold for good, it's best to opt for companies that have proven they can perform relatively well -- and continue raising their dividends -- through economic and market fluctuations."
2025-03-07,Strong Earnings Lift Abbott Laboratories Shares,Yahoo,"Health care company Abbott Laboratories (ABT) increases sales, earnings around the globe."
2025-03-08,Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT),Yahoo,"Key Insights Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$151 With US$137..."
2025-03-10,3 Reasons to Avoid ABT and 1 Stock to Buy Instead,Yahoo,"Abbott Laboratories’s 16.6% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $136.50 per share. This run-up might have investors contemplating their next move."
2025-03-12,"Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",SeekingAlpha,"Diversify Caterpillar holdings with tax-efficient strategies. Explore HD, LOW, and SNA for income replacement potential and strong dividend growth."
2025-03-12,Here's Why We Think Abbott Laboratories (NYSE:ABT) Might Deserve Your Attention Today,Yahoo,"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story..."
2025-03-12,Fidelity Select Health Care Portfolio Q4 2024 Review,SeekingAlpha,"Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500Â® index."
2025-03-13,Merck and 8 More Healthcare Stocks for Nervous Dividend Investors,MarketWatch,Merck and 8 More Healthcare Stocks for Nervous Dividend Investors
2025-03-13,Abbott (ABT) Stock Sinks As Market Gains: Here's Why,Yahoo,"Abbott (ABT) closed the most recent trading day at $130.28, moving -1.79% from the previous trading session."
2025-03-14,Is Abbott Laboratories (ABT) the Best Healthcare Stock For Long-Term Investment?,Yahoo,"We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best healthcare stocks for long-term investment. Rising Healthcare Costs and the Impact of Tariffs on the US Industry In the US, healthcare expenditures and […]"
2025-03-14,Abbott (ABT) Stock Moves -0.3%: What You Should Know,Yahoo,"Abbott (ABT) reachead $129.89 at the closing of the latest trading day, reflecting a -0.3% change compared to its last close."
2025-03-15,Citi sees overturned verdict in state case as incrementally negative for Abbott,Yahoo,"Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, which was in favor of Reckitt Benckiser’s (RBGLY) Mead Johnson unit. The jury had originally ruled that Mead Johnson was not liable for failing to warn of the risks of NEC related to its infant formulas. As a reminder, for Abbott (ABT), there is a Federal multidistrict litigation case scheduled for May 5, 2025, in Chicago. The firm anticipates that the case"
2025-03-15,Why Abbott Laboratories (ABT) Went Down On Friday?,Yahoo,"We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other Friday’s worst performing stocks. Wall Street’s main indices bounced back on Friday, erasing the entire week’s losses, as investor hopes were fueled by news that no […]"
2025-03-15,Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial,Yahoo,Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.
2025-03-15,S&P 500 Gains and Losses Today: Index Bounces Off Lows as Government Shutdown Concerns Ease,Yahoo,"The S&P 500 jumped 2.1% on Friday, March 14, wrapping up a volatile week as government shutdown concerns eased."
2025-03-15,AstraZeneca Stock Scores RS Rating Upgrade,Yahoo,"AstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83."
2025-03-15,US Equities Markets End Higher Friday Amid Expectations US Government Can Avoid Shutdown,Yahoo,US benchmark equity indexes ended higher Friday amid expectations that a looming government shutdown
2025-03-15,Top Midday Decliners,Yahoo,Li Auto (LI) shares retreated 3% Friday after the Chinese electric vehicle manufacturer reported a 1
2025-03-15,Abbott and Reckitt Fall on News of New Infant Formula Trial,Yahoo,"(Bloomberg) -- Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.Most Read from BloombergTrump DEI Purge Hits Affordable Housing GroupsHow Britain’s Most Bike-Friendly New Town Got BuiltICE Eyes Massive California Tent Facility Amid Space ConstraintsThe Dark Prophet of Car-Clogged CitiesWashington, DC, Region Br"
2025-03-15,"Abbott, Mead Johnson Face Retrial of Case Over Infant Formula",Yahoo,"Abbott Laboratories (ABT) is facing a retrial of a case, alleging its formula milk was harmful to in"
2025-03-15,"Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case",Yahoo,"Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.  Reckitt shares fell about 1.7% in London, while Abbott shares dropped 2.4% in U.S. trading.  Last October a jury had found the companies were not liable in a state lawsuit that alleged the companies’s infant formula products caused necrotizing enterocolitis, a debilitating intestinal disease that can cause bloating, vomiting and diarrhea in premature babies."
2025-03-15,Abbott Says CEO Robert B. Ford's 2024 Compensation Was $22.6 Million,Finnhub,Abbott Laboratories: * ABBOTT SAYS CEO ROBERT B. FORD'S 2024 COMPENSATION WAS$22.6MILLION- SEC FILINGFurther company coverage: ...
2025-03-16,Abbott Laboratories Basking In A Sharp Turn In Sentiment,SeekingAlpha,"Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes. Read why ABT stock is a Hold."
2025-03-17,Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?,Yahoo,"ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning."
2025-03-17,"Abbott Laboratories Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution",Yahoo,"In the last year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a substantial stake in the company which may have..."
2025-03-17,Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees,SeekingAlpha,Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a buy with a price target of $145-$160.
2025-03-18,Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?,Yahoo,"Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?"
2025-03-18,"Reckitt’s Mead Johnson, Abbott to face new trial in US infant-formula case",Yahoo,Reckitt described the re-opening of the trial as being “at complete odds with the law and the facts”.
2025-03-19,RFK Jr.’s Next Targets Are Companies Making Baby Formula,Yahoo,"(Bloomberg) -- Health and Human Services Secretary Robert F. Kennedy Jr. is taking on baby formula products, the latest in his sweeping review of ingredients used in the US food supply.Most Read from BloombergThe Dark Prophet of Car-Clogged CitiesWashington, DC, Region Braces for ‘Devastating’ Cuts from CongressNYC Plans for Flood Protection Without Federal FundsA Malibu Model for Residents on the Fire FrontlinesDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleUnder Kennedy, the"
2025-03-19,Abbott Laboratories (ABT): Among the Best Diabetes Stocks to Buy According to Billionaires,Yahoo,"We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO estimates […]"
2025-03-20,Defensive Stocks For Unpredictable Trump Policy,SeekingAlpha,"Navigate market volatility with defensive stocks, bonds, and gold."
2025-03-20,Invesco Health Care Fund Q4 2024 Commentary,SeekingAlpha,"Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities."
2025-03-20,Abbott (ABT) Gains But Lags Market: What You Should Know,Yahoo,"In the most recent trading session, Abbott (ABT) closed at $127.42, indicating a +0.89% shift from the previous trading day."
2025-03-21,Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up,Yahoo,"Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key..."
2025-03-21,2025 Dividend Kings: Strong Run Continues,SeekingAlpha,"Discover the top-performing Dividend Kings of 2025, outperforming the S&P 500 by 4.57%. Click here to explore more promising picks."
2025-03-24,Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease,Yahoo,Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment of severe calcification in coronary arteries prior to stenting. The TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) clinical trial will enroll up to 335 people in 47 sites in the U.S.
2025-03-24,Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains,Yahoo,"Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT."
2025-03-24,Jim Cramer On Abbott Laboratories (ABT): “Abbott Labs Stock Is Back on My Radar”,Yahoo,"We recently published a list of Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer […]"
2025-03-25,ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System,Yahoo,"Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages."
2025-03-25,Abbott gets FDA nod to begin IVL trial after rivals buy up competition,Yahoo,"J&J acquired the IVL device maker Shockwave Medical last year for $13.1 billion, and Boston Scientific agreed to buy Bolt Medical in January for up to $664 million."
2025-03-25,Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know,Yahoo,"Abbott (ABT) reachead $127.21 at the closing of the latest trading day, reflecting a +0.69% change compared to its last close."
2025-03-25,Abbott Laboratories (NYSE:ABT) Receives FDA Approval For Coronary IVL System Trial In US,Yahoo,"Abbott Laboratories (NYSE:ABT) has caught investor attention with the FDA’s approval of an Investigational Device Exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System, a significant development within the realm of coronary artery disease treatment. This announcement comes in conjunction with the company's recent robust Q4 2024 earnings results, reporting net income and diluted EPS growth. Additionally, Abbott declared its 405th consecutive quarterly dividend and outlined..."
2025-03-26,Diamond Hill Capital is Crazy About Abbott Laboratories (NYSE:ABT),Yahoo,"We recently published a list of Diamond Hill Capital Stock Portfolio: Top 10 Stock Picks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other top 10 stock picks of Diamond Hill Capital. Heather Brilliant, CFA, serves as CEO for Diamond Hill Capital and joined the firm in 2019, […]"
2025-03-26,Abbott Hosts Conference Call for First-Quarter Earnings,Yahoo,"Abbott (NYSE: ABT) will announce its first-quarter 2025 financial results on Wednesday, April 16, before the market opens."
2025-03-26,2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income,Yahoo,"AbbVie's shares  dropped off a cliff  in November after it announced a clinical setback for emraclidine, an investigational schizophrenia treatment it got in an $8.7 billion acquisition.  Investors were worried the company spent nearly $9 billion for nothing, which is understandable."
2025-03-27,Abbott Laboratories (ABT): Among Dividend Zombies to Invest in,Yahoo,"We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other dividend zombies to invest in. The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing on the […]"
2025-03-27,Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms,Yahoo,"Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies. The company will further expand use of Volt in EU markets throughout the second half of the year."
2025-03-27,Abbott Receives CE Mark For Its Volt(TM) Pulsed Field Ablation System To Treat Patients With Abnormal Heart Rhythms,Finnhub,Abbott Laboratories: * ABBOTT RECEIVES CE MARK FOR ITS VOLT™ PULSED FIELDABLATIONSYSTEM TO TREAT PATIENTS WITH ABNORMAL HEART RHYTHMSSource text:Further company coverage: ...
2025-03-28,Is Abbott Laboratories (ABT) the Best S&P 500 Stock to Buy for Dividend Growth?,Yahoo,"We recently published a list of the 10 Best S&P 500 Stocks to Buy for Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best S&P 500 stocks for dividend growth. Dividend stocks have been attracting increasing interest lately, particularly following the tech sector’s […]"
2025-03-28,Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the 13% YoY shareholder returns,Yahoo,"If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share..."
2025-03-28,Abbott snags early CE mark for Volt PFA device,Yahoo,"With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market."
2025-03-28,Why Abbott Laboratories (ABT) Surged On Thursday?,Yahoo,"We recently published a list of 10 Stocks Jump, Defy Market Uncertainties on Thursday. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that jumped, defying market uncertainties on Thursday. The stock market extended losses on Thursday, with all the major indices ending in the […]"
2025-03-28,Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday,Yahoo,"Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe.  The CE mark is an affirmation by a product's manufacturer that it conforms with a range of standards covering aspects such as health and safety.  In its press release touting the development, Abbott wrote that roughly 8 million people in Europe over the age of 65 are coping with atrial fibrillation, and that figure is anticipated to double within three decades."
2025-03-28,S&P 500 Gains and Losses Today: GM Stock Tumbles After Trump Declares Auto Tariffs,Yahoo,"The S&P 500 declined 0.3% on Thursday, March 27, after the White House announced a 25% tariff on auto imports will take effect next week."
2025-03-28,Equity Markets On Track to Close Lower Following Trump's Auto Tariffs,Yahoo,"US benchmark equity indexes are on track to close lower on Thursday, as markets weigh the impact of"
2025-03-29,3 Relatively Safe Stocks to Buy Right Now,Yahoo,"Investing in stocks comes with risks.  David Jagielski (Abbott Laboratories): If you're looking for safety within the healthcare sector, a top name to consider right now is Abbott Laboratories.  For starters, it offers an above-average dividend yield of 1.9% (the S&P 500 average is 1.4%)."
2025-03-29,"Top Research Reports for McDonald's, Abbott & O'Reilly Automotive",Yahoo,"Today's Research Daily features new research reports on 12 major stocks, including McDonald's Corp. (MCD), Abbott Laboratories (ABT) and O'Reilly Automotive, Inc. (ORLY), as well as a micro-cap stock MIND Technology, Inc. (MIND)."
2025-03-31,GE HealthCare's Latest Product Launch to Boost Cardiology Care,Yahoo,GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.
2025-03-31,"The Zacks Analyst Blog Highlights McDonald's, Abbott Laboratories, O'Reilly Automotive and MIND Technology",Yahoo,"McDonald's, Abbott Laboratories, O'Reilly Automotive and MIND Technology are part of the Zacks top Analyst Blog."
2025-03-31,New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve,Yahoo,"Abbott (NYSE: ABT) today announced late-breaking data from its TRILUMINATE™ Pivotal trial that show the TriClip™ transcatheter edge-to-edge repair (TEER) system to treat tricuspid regurgitation (TR), or a leaky heart valve, offers substantial and sustained improvements in the severity of TR after two years. The results also demonstrate the TriClip device significantly reduced the rate of hospitalizations due to heart failure compared to medical therapy, while offering long-term quality-of-life b"
2025-04-01,ABT Stock to Gain From Early CE Mark Approval of Volt PFA System,Yahoo,Abbott achieves early CE Mark approval for the Volt PFA system.
2025-04-01,ABT Stock Gains Following the Positive TRILUMINATE Trial Results,Yahoo,"Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25."
2025-04-01,Abbott (ABT) Outperforms Broader Market: What You Need to Know,Yahoo,"In the latest trading session, Abbott (ABT) closed at $132.65, marking a +1.4% move from the previous day."
2025-04-01,Best Dividend Aristocrats For April 2025,SeekingAlpha,"Dividend Aristocrats in 2025 show resilience, outperforming the S&P 500. Click here to read what investors need to know."
2025-04-02,Abbott Laboratories (NYSE:ABT) Shows Promising Results in Heart Valve Device Study,Yahoo,"Abbott Laboratories (NYSE:ABT) recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid regurgitation. This medical breakthrough, coupled with Abbott's consistent financial performance, including strong earnings for the fourth quarter of 2024 and strategic dividend announcements, aligns with a 17% rise in its stock price over the last quarter. Despite market turbulences and mixed..."
2025-04-03,Court Denies Abbott's Summary Judgment Motion In Patent Infringement Case: A Lesson In Joinder Rules,Finnhub,"In a recent decision from the United States District Court for the District of Massachusetts, the district court denied Abbott Laboratories' motion for summary judgment in a patent infringement case..."
2025-04-04,Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?,Yahoo,"According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?"
2025-04-04,The Dow Needs a Refresh. These Stocks Could Make It Sing.,MarketWatch,The Dow Needs a Refresh. These Stocks Could Make It Sing.
2025-04-04,Reasons to Add ABT Stock to Your Portfolio Right Now,Yahoo,"Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning."
2025-04-04,Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks,Yahoo,Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.
2025-04-04,Abbott (ABT) Stock Moves -0.23%: What You Should Know,Yahoo,"The latest trading day saw Abbott (ABT) settling at $131.63, representing a -0.23% change from its previous close."
2025-04-04,​RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade),SeekingAlpha,RxSight faces revenue decline and rising competition in the IOL market. Explore the impacts of economic uncertainties and why a Hold rating is suggested.
2025-04-04,Global Expansion in EPD and Innovations Support Abbott Stock,Yahoo,"Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre."
2025-04-05,Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals?,Yahoo,"It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has..."
2025-04-05,The Dow Needs A Refresh. These New Members Could Make It Sing.,Yahoo,"The Dow Jones Industrial Average has lagged behind its flashier cousin, the S&P 500 index, in recent years, James Glassman writes in a guest commentary."
2025-04-06,Abbott Laboratories (ABT): One of the Best Dividend Kings to Buy for Safe Dividend Growth,Yahoo,"We recently published a list of the 12 Best Dividend Kings to Buy For Safe Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best dividend kings. The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by […]"
2025-04-07,5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem,Yahoo,"Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA."
2025-04-08,"The Zacks Analyst Blog Highlights Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare",Yahoo,"Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare are included in this Analyst Blog."
2025-04-08,Is Abbott Laboratories (ABT) the Most Profitable Dividend Stock to Buy Now?,Yahoo,"We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other profitable dividend stocks. When it comes to profits, dividend investing is the first thing that springs to mind. Dividends represent a portion of […]"
2025-04-09,Abbott (ABT) Earnings Expected to Grow: Should You Buy?,Yahoo,Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2025-04-09,"TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock?",Yahoo,"TriSalus Life Sciences, Inc. (TLSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road."
2025-04-09,Abbott Laboratories' (NYSE:ABT) institutional investors lost 5.9% over the past week but have profited from longer-term gains,Yahoo,Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...
2025-04-09,ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps,Yahoo,"ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety."
2025-04-10,Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device,Yahoo,Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day period.
2025-04-10,"Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus",Yahoo,"ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 performance."
2025-04-10,Here's Why You Should Add Cencora Stock to Your Portfolio Now,Yahoo,"COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe."
2025-04-10,Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day,Yahoo,Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day.
2025-04-10,Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On,Yahoo,"Investors looking to maintain exposure to healthcare can invest in large-cap U.S.-based companies like UHS, BMRN and ABT."
2025-04-10,"Abbott Laboratories stock rises Wednesday, still underperforms market",MarketWatch,"Abbott Laboratories stock rises Wednesday, still underperforms market"
2025-04-11,Seeking Clues to Abbott (ABT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics,Yahoo,"Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025."
2025-04-11,Abbott (ABT) Stock Moves -2%: What You Should Know,Yahoo,"Abbott (ABT) closed at $124.50 in the latest trading session, marking a -2% move from the prior day."
2025-04-12,"Dividend Champion, Contender, And Challenger Highlights: Week Of April 13",SeekingAlpha,Read here for highlights on recent and upcoming dividend related activity for dividend stocks on the Dividend Champions list.
2025-04-13,What Is Abbott Laboratories's (NYSE:ABT) Share Price Doing?,Yahoo,Today we're going to take a look at the well-established Abbott Laboratories ( NYSE:ABT ). The company's stock saw a...
2025-04-13,Wall Street Week Ahead,SeekingAlpha,"Stay informed with Wall Street updates! Key economic reports, earnings releases, and market insights ahead. Explore trends & navigate volatility effectively."
2025-04-14,BAX Stock Declines Despite Latest Product Launch Boosting Patient Care,Yahoo,"Baxter aims to promote enhanced patient care through the evolution of its latest product, which enables direct accessibility in the operating room."
2025-04-15,Badger Meter Gears Up to Report Q1 Earnings: What's in the Offing?,Yahoo,"BMI's performance is likely to have benefited from demand for its solutions. However, the uncertain macro backdrop, higher costs and competition are concerns."
2025-04-15,How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings,Yahoo,"Abbott Laboratories (NYSE:ABT) will release its first-quarter earnings results before the opening bell on Wednesday, April 16. Analysts expect the company to report quarterly earnings at $1.07 per share, up from 98 cents per share in the year-ago period. According to data from Benzinga Pro, Abbott Laboratories projects quarterly revenue at $10.41 billion, compared to $9.96 billion a year earlier. On March 10, Bank of America Securities analyst Travis Steed maintained Abbott with a Buy rating and"
2025-04-15,Abbott Laboratories (ABT) Q1 Earnings: What To Expect,Yahoo,Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the bell. Here’s what to look for.
2025-04-15,"The Zacks Analyst Blog Abbott, Taiwan Semiconductor, American Express, ManpowerGroup and D.R. Horton",Yahoo,"Abbott, Taiwan Semiconductor, American Express, ManpowerGroup and D.R. Horton are included in this Analyst Blog."
2025-04-15,5 Top Stock Charts for This Week,Yahoo,"Tracey Ryniec talks about a new strategy for Q1 earnings season, including impacts of the tariffs, on ABT, TSM, AXP, MAN, and DHI."
2025-04-16,"Top Midday Stories: Nvidia, AMD Flag Looming Charges Tied to China Export Licenses; ASML Shares Fall on Sales Miss, Downbeat Guidance",Yahoo,"All three major US stock indexes were in the red at midday Wednesday, with the Nasdaq Composite down"
2025-04-16,Abbott Labs Forecasts Tariff Impact of a ‘Few Hundred Million Dollars’,Yahoo,"Abbott Laboratories forecasts an impact of ""a few hundred million dollars"" this year from Trump administration tariffs, Chief Executive Robert Ford told analysts Wednesday.  The healthcare company sees the costs starting in the third quarter.  Ford told analysts it is too early to simply double the 2025 estimate for how tariffs might affect Abbott in future years, but the company can cover them in the near term."
2025-04-16,Abbott Labs sees tariffs costing ‘a few hundred million dollars’ this year,MarketWatch,Abbott Labs sees tariffs costing ‘a few hundred million dollars’ this year
2025-04-16,Pre-Markets Open in The Red,Yahoo,Pre-Markets Open in The Red
2025-04-16,Abbott Laboratories stock pops on earnings beat,Yahoo,"Abbott Laboratories (ABT) stock is gaining after the healthcare tech company reported a first quarter earnings beat. Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani sits down with Madison Mills and Brad Smith on Morning Brief to discuss the earnings print and the latest developments in the healthcare sector. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here."
2025-04-16,Abbott Laboratories Maintains 2025 Outlook as First-Quarter Earnings Top Views,Yahoo,Abbott Laboratories (ABT) affirmed its full-year outlook on Wednesday as the healthcare company repo
2025-04-16,Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations,Yahoo,Abbott Labs posts first-quarter sales that missed analysts’ estimates but rose 4% from a year earlier.
2025-04-16,Abbott expects a ‘few hundred million’ in tariff costs in 2025,Yahoo,"CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs."
2025-04-16,"Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty",Yahoo,"Abbott Laboratories (NYSE:ABT) on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. First-quarter sales increased 4% on a reported basis, 6.9% on an organic basis, or 8.3% when excluding COVID-19 testing-related sales. The U.S. MedTech giant reported adjusted EPS of $1.09, beating the consensus of $1.07 and the management guidance of $1.05-$1.09. “Once again, Abbott’s diversified business model delivered top-tie"
2025-04-16,"Compared to Estimates, Abbott (ABT) Q1 Earnings: A Look at Key Metrics",Yahoo,"While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values."
2025-04-16,"Nvidia, ASML, Abbott Labs: Stocks to watch today",Yahoo,"U.S. stock futures moved lower Wednesday as investors braced for another wave of geopolitical and earnings headlines. S&P 500 futures were down 0.5%, the Dow hovered near flat, and Nasdaq futures dropped more than 1%."
2025-04-16,"Abbott Bounds Off 50-Day Line, Shrugging Off Covid Test Malaise",Yahoo,Abbott stock jumped after the market opened Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests.
2025-04-16,Abbott (ABT) Q1 Earnings Beat Estimates,Yahoo,"Abbott (ABT) delivered earnings and revenue surprises of 1.87% and 0.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?"
2025-04-16,Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it,Yahoo,"HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance."
2025-04-16,"Abbott Labs 1Q Profit Jumps on Gains in Nutrition, Medical Devices",Finnhub,By Dean Seal Abbott Labs recorded higher earnings and revenue in the first quarter as strong demand for its nutritional products and medical devices offset weakness in other segments. The...
2025-04-16,Abbott Labs Bracing for Tariffs as Profits Rise -- Update,Finnhub,By Dean Seal Abbott Labs boosted its earnings in the first quarter and hinted that its full-year guidance might have gotten a lift were it not for looming cost hikes from the recent tariff war....
2025-04-16,Wall Street Lunch: Retail Sales Defy Expectations Amid Consumer Confidence Distress,SeekingAlpha,"Consumer confidence may be tumbling, but the willingness to spend didnât crumble last month."
2025-04-16,"Abbott backs profit forecast, to invest $500 million in US amid tariffs",Finnhub,Medical device maker Abbott Laboratories maintained its annual profit forecast on Wednesday and said it expected the U.S. tariffs to hit earnings by a few hundred million dollars. ...
2025-04-16,Abbott Laboratories (NYSE:ABT) Posts Q1 Sales In Line With Estimates,Yahoo,"Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4% year on year to $10.36 billion. Its non-GAAP profit of $1.09 per share was 1.7% above analysts’ consensus estimates."
2025-04-16,Abbott: Q1 Earnings Snapshot,Yahoo,"The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.07 per share. The maker of infant formula, medical devices and drugs posted revenue of $10.36 billion in the period, which did not meet Street forecasts."
2025-04-16,Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings,Yahoo,Strength in Analytical Instruments and Specialty Diagnostics segments is likely to have driven Thermo Fisher's first-quarter 2025 performance.
2025-04-16,Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance,Yahoo,"Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2025."
2025-04-16,Abbott Laboratories (ABT) Q1 2025 Earnings Call Transcript,SeekingAlpha,"Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Conference Call April 16, 2025 9:00 AM ETCompany ParticipantsMike Comilla - VP, IRRobert Ford - Chairman and..."
2025-04-16,"Abbott maintains profit forecast, plans new US investments amid tariff risks",Finnhub,Abbott Laboratories maintained its annual profit forecast on Wednesday and announced $500 million in investments towards U.S. manufacturing and research in the face of tariff-induced uncertainty. ...
2025-04-16,Abbott beats quarterly profit estimate on strong medical device demand,Finnhub,"Abbott Laboratories beat Wall Street estimates for first-quarter profit on Wednesday, buoyed by strong demand for diabetes care and other medical devices. The company also maintained its full-year..."
2025-04-16,Financial stocks dominate earnings slate,MarketWatch,Financial stocks dominate earnings slate
2025-04-16,“Rotation Carnage”: Jim Cramer Blames a Bad Rotation for Abbott Laboratories (ABT)’s Fall from Grace,Yahoo,"We recently published a list of Jim Cramer’s Game Plan: 15 Stocks to Watch. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discusses. On Friday, Mad Money host Jim Cramer outlined what investors should focus on in the week, especially pointing […]"
2025-04-17,Abbott price target raised to $140 from $138 at Evercore ISI,Yahoo,"Evercore ISI raised the firm’s price target on Abbott (ABT) to $140 from $138 and keeps an Outperform rating on the shares after the company reported organic growth of 6.9% in Q1 and the strength was “broad based” along with an overall EPS beat as earnings grew about 11%. In an environment where uncertainty is the dominating theme, the ability to protect the bottom-line should be appreciated, says the analyst, who calls Abbott “the perfect stock to weather macro uncertainty.” Published first on"
2025-04-17,"Company News for Apr 17, 2025",Yahoo,"Companies In The News Article Are:AMD,ABT, PGR, TRV"
2025-04-17,Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025,Yahoo,"In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17.6% of the US economy, an increase of 17.4% from 2022. The growth of Medicare and private […]"
2025-04-17,Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...,Yahoo,"Abbott Laboratories (ABT) reports robust earnings with a 12.5% increase in medical devices sales and a 7% rise in nutrition, despite a decline in diagnostics due to reduced COVID-19 testing."
2025-04-17,Q1 2025 Abbott Laboratories Earnings Call,Yahoo,Q1 2025 Abbott Laboratories Earnings Call
2025-04-17,"Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs",Yahoo,Barclays outlines which MedTech stocks could feel the most pressure from Trump's anticipated global pharmaceutical tariffs
2025-04-17,"Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers",Yahoo,"Josh Lipton, joined by Defiance ETFs CEO and chief investment officer Sylvia Jablonski, examines some of the trading day's trending tickers. Hertz (HTZ) shares pop after Bill Ackman-led Pershing Square Capital Management disclosed a stake of 12.7 million shares of the rental car company's stock. Abbott Laboratories (ABT) gained after the medical tech company reported stronger-than-expected earnings. Interactive Brokers (IBKR) tumbles after earnings results missed analyst estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here."
2025-04-17,Is Abbott Laboratories (ABT) the Best Dividend Monarch to Invest in Now?,Yahoo,"We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware […]"
2025-04-17,"Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities",Yahoo,Abbott Laboratories shares surged Wednesday after the medical device maker said it plans to invest $500 million in U.S. operations and topped Wall Street’s expectations with its first-quarter results.
2025-04-17,Abbott Laboratories (NYSE:ABT) Reports Q1 Sales And Income Growth With Earnings At US$0.76,Yahoo,"Abbott Laboratories (NYSE:ABT) recently reported positive Q1 2025 results, showing increased sales and net income, which may have bolstered its share price by 14% last quarter. The enhanced financial performance, including a rise in diluted EPS, highlighted profitability improvements. This, coupled with ongoing stock buybacks and a longstanding commitment to dividends, likely contributed to investor confidence. Despite broader market concerns such as U.S.-China trade tensions impacting tech..."
2025-04-17,Health Care Stays Ahead of Market Amid Defensive Bias - Health Care Roundup,MarketWatch,Health Care Stays Ahead of Market Amid Defensive Bias - Health Care Roundup
2025-04-17,"Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market",Yahoo,ABT delivers a strong underlying base business performance for the first quarter of 2025.
2025-04-17,Health Care Roundup: Market Talk,DowJones,Health Care Roundup: Market Talk
2025-04-17,"United Airlines & Abbott Labs earnings, Ackman's Hertz stake",Yahoo,"Brad Smith outlines some of the top stories on Wall Street in just 60 seconds on today's Market Minute. United Airlines (UAL) shares rise after reporting earnings results and providing investors with dual outlooks depending on the health of the US economy. Abbott Laboratories (ABT) stock rises after the medical supply company reported better-than-expected earnings results. Hertz (HTZ) shares surge after Bill Ackman-led Pershing Square Capital Management disclosed a large stake in the rental car company. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute."
2025-04-17,"Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know",Yahoo,"Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) jumped 5.4% in the morning session after the company reported decent first-quarter 2025 results with revenue in line, although its organic revenue fell slightly short of Wall Street's estimates. EPS in the quarter beat slightly, while full-year EPS guidance met expectations. The full-year sales outlook was also maintained, which was encouraging despite the uncertain macro backdrop."
2025-04-18,"Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever",Yahoo,Earnings preview of key companies reporting next week and what to look out for.
2025-04-18,"Nvidia, AMD see charges due to new China export rules: Morning Buzz",Yahoo,"The major averages were broadly lower near noon, with the Nasdaq down over 300 points amid escalating trade tensions and new export restrictions.​ This follows the U.S. government’s decision to tighten export controls on advanced AI-related computer chips.​ The recent U.S. actions have intensified concerns over a potential trade war. President Donald Trump has announced a new investigation into critical mineral imports and imposed steep tariffs on Chinese imports. In retaliation, China has incre"
2025-04-19,Abbott Labs' Rally Is Well Deserved - Fade The Rally For Now,SeekingAlpha,"Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while staying poised to outperform."
2025-04-20,Jim Cramer Applauds Abbott Laboratories (ABT): “A Tour de Force Quarter – Robert Ford Is Keeping the Miles White Legacy Alive”,Yahoo,"We recently published a list of Jim Cramer Defended American Superiority and Discussed These 13 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of […]"
2025-04-20,"Insiders At Abbott Laboratories Sold US$3.3m In Stock, Alluding To Potential Weakness",Yahoo,"Over the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which may..."
2025-04-21,Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow,Yahoo,Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting results tomorrow after market close. Here’s what investors should know.
2025-04-22,What To Expect From Penumbra’s (PEN) Q1 Earnings,Yahoo,Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know.
2025-04-22,Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow,Yahoo,Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for.
2025-04-22,What To Expect From Boston Scientific’s (BSX) Q1 Earnings,Yahoo,Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to look for.
2025-04-24,EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes,Yahoo,"Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre."
2025-04-24,"The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories, RTX, Investors Title and Armanino Foods of Distinction",Yahoo,"Coca-Cola, Abbott Laboratories, RTX, Investors Title and Armanino Foods of Distinction are part of the Zacks top Analyst Blog."
2025-04-24,Calculating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT),Yahoo,Key Insights Abbott Laboratories' estimated fair value is US$132 based on 2 Stage Free Cash Flow to Equity Current...
2025-04-24,"Top Analyst Reports for Coca-Cola, Abbott & RTX",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Co. (KO), Abbott Laboratories (ABT) and RTX Corp. (RTX), as well as two micro-cap stocks Investors Title Co. (ITIC) and Armanino Foods of Distinction, Inc. (AMNF)."
2025-04-26,Tariffs Cast a Shadow on Abbott's 2025 View: Time to Sell ABT Stock?,Yahoo,"With certain devices being imported into the United States from overseas, tariff-induced cost pressure is set to rise for Abbott from the third quarter of 2025."
2025-04-27,"New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib",Yahoo,Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA System for the treatment of atrial fibrillation (AFib). The data also highlights the excellent safety profile of the Volt PFA System alongside the system's ability to achieve results with fewer therapy applications (just 4.7 applications per vein on average) than on-market competitive PFA systems.
2025-04-28,3 Dividend Stocks to Buy and Hold for the Next Decade,Yahoo,"Three Motley Fool contributors believe they've identified fantastic dividend stocks to buy and hold for the next decade.  Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Pfizer (NYSE: PFE)."
2025-04-28,"The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic",Yahoo,"Abbott Laboratories, Boston Scientific and Medtronic are included in this Analyst Blog."
2025-04-28,Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price,Yahoo,"There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want..."
2025-04-28,"Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology",Yahoo,"Abbott (NYSE: ABT) today announced late-breaking data from the AVEIR™ Conduction System Pacing (CSP) acute clinical feasibility study, which demonstrated the safety and performance of the investigational AVEIR CSP leadless pacemaker technology. The AVEIR CSP acute clinical feasibility study is the world's first assessment of a leadless pacemaker delivering conduction pacing to the heart's left bundle branch (LBB) area. CSP is a novel pacing approach that targets the LBB area by enabling pacing t"
2025-04-29,"Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information",Yahoo,"Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology1, today announced that it has entered a first-of-its-kind agreement to integrate data from its world-leading1 Libre CGM systems directly into Epic's electronic health record systems in the U.S. The collaboration aims to improve workflow efficiency for providers through Epic's Aura software, which brings health systems together with diagnostics labs and medical device manufacturers."
2025-04-29,Abbott Laboratories (NYSE:ABT) Unveils Breakthrough Leadless Pacemaker Advances In New Clinical Trials,Yahoo,"Abbott Laboratories (NYSE:ABT) recently announced promising results from its AVEIR Conduction System Pacing study, showcasing its innovative leadless pacemaker technology. Over the last quarter, the company's stock price movement was relatively flat, rising by 1.15%. This modest gain aligns with broader market trends, where major indexes like the Dow had a slight decline and tech stocks saw some losses. Abbott's positive product announcements, alongside stable earnings and continued dividend..."
2025-04-30,Best Dividend Aristocrats For May 2025,SeekingAlpha,"Dividend Aristocrats lag behind the S&P 500 in April, but 25 are undervalued with 10% returns potential. Click to read about promising Aristocrats."
2025-05-01,MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races,Yahoo,"Abbott (NYSE: ABT), the global healthcare company, and MotoAmerica, the premier motorcycle road racing series in North America, announced today that MotoAmerica is the first professional sports organization worldwide to use Abbott's groundbreaking blood test to help assess suspected concussions for riders in the on-site medical facilities at all races."
2025-05-01,Abbott Laboratories (ABT): Among the Best Stocks to Buy During Recession,Yahoo,"We recently compiled a list of the 15 Best Stocks to Buy During Recession. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. As per BlackRock, 2025 started with a bumpy ride for the US stocks. That being said, the asset manager believes that the sentiment […]"
2025-05-01,"If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?",Yahoo,Medical stocks could see a resurgence if the economy hits a speed bump due to tariffs. But which health care stocks are worth watching?
2025-05-01,Abbott Laboratories (ABT): Jim Cramer Calls It a ‘Tour de Force’ — Why He’s Still Amazed at This Stock,Yahoo,"We recently published a list of How Did Jim Cramer’s 12 Bold Predictions Play Out?. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer recently discussed. During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in artificial […]"
2025-05-02,These companies are emerging as potential winners in Trump’s trade war,MarketWatch,These companies are emerging as potential winners in Trump’s trade war
2025-05-02,Investors in Abbott Laboratories (NYSE:ABT) have seen notable returns of 52% over the past five years,Yahoo,"The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up..."
2025-05-03,Abbott Laboratories First Quarter 2025 Earnings: EPS Misses Expectations,Yahoo,Abbott Laboratories ( NYSE:ABT ) First Quarter 2025 Results Key Financial Results Revenue: US$10.4b (up 4.0% from 1Q...
2025-05-03,Comstock Resources to List Shares on NYSE Texas,MarketWatch,Comstock Resources to List Shares on NYSE Texas
2025-05-06,Tariff-driven disruptions in regulatory compliance,Yahoo,"Though designed as economic tools, tariffs have ripple effects that extend into the regulatory framework of the medical device sector."
2025-05-06,Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now?,Yahoo,Smart Beta ETF report for VALQ
2025-05-06,Fidelity Value Discovery Fund Q1 2025 Commentary,SeekingAlpha,"For Q1 2025, Fidelity Value Discovery Fund gained 2.16%, outpacing the 1.64% advance of the benchmark Russell 3000Â® Value Index. Click here to read the full commentary. "
2025-05-06,1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar,Yahoo,"""Too big to fail"" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth."
2025-05-06,Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK),Yahoo,"Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers."
2025-05-07,Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains,Yahoo,"Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The […]"
2025-05-07,Jim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way!,Yahoo,"We recently published a list of Jim Cramer Talked About These 7 Stocks Recently. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed recently. On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as […]"
2025-05-07,2024 Total Dividend Income And Portfolio Update,SeekingAlpha,2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.
2025-05-07,Impressive Earnings May Not Tell The Whole Story For Abbott Laboratories (NYSE:ABT),Yahoo,"Abbott Laboratories ( NYSE:ABT ) announced strong profits, but the stock was stagnant. We did some digging, and we..."
2025-05-07,Fidelity Select Health Care Portfolio Q1 2025 Commentary,SeekingAlpha,"For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary. "
2025-05-07,A Look Back at Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Neogen (NASDAQ:NEOG) Vs The Rest Of The Pack,Yahoo,"Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Neogen (NASDAQ:NEOG) and its peers."
2025-05-08,Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent,Finnhub,ABBOTT PARK - Abbott announced the creation of the inaugural 'Abbott Dream Team.'The program will seek out talented soccer players from across the United States and give them a once-in-a-lifetime...
2025-05-08,Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Abbott Laboratories (NYSE:ABT),Yahoo,"As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Abbott Laboratories (NYSE:ABT) and its peers."
2025-05-08,Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?,Yahoo,"Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains."
2025-05-09,"The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar",Yahoo,"NVIDIA, Abbott Laboratories, Linde and Tredegar are part of the Zacks top Analyst Blog"
2025-05-09,Why Abbott Laboratories (ABT) is Among the Best Medical Device Stocks to Buy Now,Yahoo,"We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs are […]"
2025-05-09,"Top Stock Reports for NVIDIA, Abbott Laboratories & Linde",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG)."
2025-05-10,Trump is hailing $2 trillion in new company investments. Most of it comes from Big Tech.,Yahoo,"President Trump has touted $2 trillion in new company investments since Inauguration Day. The lion's share comes from Big Tech, according to a Yahoo Finance analysis."
2025-05-10,"Dividend Champion, Contender, And Challenger Highlights: Week Of May 11",SeekingAlpha,"See here for weekly updates on Dividend Champions, Contenders & Challengers. Find dividend changes, ex-dividend dates & payment schedules."
2025-05-11,Is Abbott Laboratories' (NYSE:ABT) Latest Stock Performance A Reflection Of Its Financial Health?,Yahoo,Most readers would already be aware that Abbott Laboratories' (NYSE:ABT) stock increased significantly by 5.0% over the...
2025-05-12,Abbott Laboratories (ABT) Benefitted From Better Execution,Yahoo,"Diamond Hill Capital, an investment management company, released its “Large Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets exhibited a mixed performance in Q1 as the new presidential administration generated significant buzz with a flurry of actions, leaving investors uncertain about the future direction. The portfolio trailed […]"
2025-05-14,BlackRock Health Sciences Opportunities Fund Q1 2025 Commentary,SeekingAlpha,"BlackRock Health Sciences Opportunities Fund posted returns of 3.66% (Institutional shares) and 3.60% (Investor A shares, without sales charge) for the first quarter of 2025."
2025-05-14,IXJ: Healthcare Sector Dashboard For May,SeekingAlpha,"This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Read the full analysis here on Seeking Alpha, updated for May 2025."
2025-05-15,Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes,Yahoo,"Abbott (NYSE: ABT) today announced results from its REFLECT real-world studies that show the use of FreeStyle Libre® continuous glucose monitoring (CGM) technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes. For the first time, data show that CGM technology can help lessen the severity of cardiovascular complications – regardless of a prior history of low blood sugar events or heart disease-related hospitalizations –"
2025-05-15,MotoAmerica is Changing Concussion Safety,Finnhub,The world's fastest sport is making a major shift into safety. MotoAmerica is the first sports organization to use Abbott's rapid blood test for concussion evaluation. It will be on site for all...
2025-05-15,Abbott Laboratories' (NYSE:ABT) institutional investors lost 4.0% last week but have benefitted from longer-term gains,Yahoo,"Key Insights Given the large stake in the stock by institutions, Abbott Laboratories' stock price might be vulnerable..."
2025-05-15,Abbott Announces Results from Its Reflect Real-World Studies That Show the Use of Freestyle Libre®? Continuous Glucose Monitoring Technology,Finnhub,Abbott announced results from its REFLECT real-world studies that show the use of FreeStyle Libre®? continuous glucose monitoring technology is associated with a significant reduction in the risk of...
2025-05-16,Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue?,Yahoo,Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2025-05-16,Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?,Yahoo,"HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However, macro challenges may hurt performance."
2025-05-16,Abbott Laboratories (NYSE:ABT) Announces Libre Technology Reduces Heart Hospitalization Risk for Diabetics,Yahoo,"Abbott Laboratories (NYSE:ABT) has recently announced compelling study findings about its FreeStyle Libre® technology, which show a decrease in hospitalization risks for diabetes patients, potentially reducing healthcare costs. This news underscores the positive advancements in the company’s product line. Meanwhile, recent earnings with a reported increase in both sales and net income, alongside reaffirmed growth guidance, reflect a strong financial position. In the broader market, index..."
2025-05-17,3 Magnificent Stocks That Are Passive Income Machines,Yahoo,Abbott Laboratories is a dividend stock you can buy and (almost) forget about.  AbbVie has proved its resilience by becoming stronger after losing patent exclusivity for its blockbuster drug Humira.  Johnson & Johnson is a seasoned dividend payer for all seasons.
2025-05-19,"Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs",Yahoo,"Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes."
2025-05-19,Abbott Laboratories (ABT)’s Libre Linked to Fewer Heart Hospitalizations in Diabetes,Yahoo,"Abbott Laboratories (NYSE:ABT) recently shared findings from its REFLECT real-world studies, revealing that the use of its FreeStyle Libre® continuous glucose monitoring (CGM) system is linked to a notable decrease in hospitalizations for heart-related complications among people with diabetes. For the first time, the data demonstrate that CGM technology can reduce the severity of cardiovascular […]"
2025-05-20,Solid Results Boosted Abbott Laboratories’ (ABT) Performance in Q1,Yahoo,"Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ended Q1 down 4.3%, marking a turbulent start to 2025. The volatility that began in February was triggered by factors including policy […]"
2025-05-20,Janus Henderson Global Life Sciences Diversified ADR Managed Account Q1 2025 Commentary,SeekingAlpha,The Portfolio returned 1.36% (gross) and the MSCI World Health Care Index SM returned 5.29%.
2025-05-20,Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks,Yahoo,"As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers."
2025-05-21,Do Abbott Laboratories' (NYSE:ABT) Earnings Warrant Your Attention?,Yahoo,"Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks..."
2025-05-21,Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity,SeekingAlpha,Senseonics recently introduced a 365-day Continuous Glucose Monitoring system. Click here to read why SENS stock is a Strong Buy.
2025-05-21,Best Dividend Kings - May 2025,SeekingAlpha,"Dividend Kings have outperformed the S&P 500 year-to-date, but recent momentum has slowed. Discover the full story here."
2025-05-23,Abbott Laboratories (ABT) was up 16% in Q1,Yahoo,"Polen Capital, an investment management company, released its “Polen Global Growth Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets experienced a surge in volatility in 2025 due to US tariffs, with the “Magnificent 7” falling 15% and semiconductors dropping 19%. U.S. stocks lagged, with international equities […]"
2025-05-23,Was Jim Cramer Right About Abbott Laboratories (ABT)?,Yahoo,"We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 20, a caller asked whether to hold or buy more shares of Abbott Laboratories […]"
2025-05-23,2 Dividend Stocks to Buy With $500 and Hold Forever,Yahoo,Zoetis is a leading animal health company with a deep lineup and significant long-term tailwinds.  Abbott Labs has a diversified portfolio of medical devices and several attractive growth avenues.  The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest.
2025-05-23,From Acquisition to Advantage: Abbott's Growth in Heart Care,Yahoo,"Abbott's moat is influenced by its market dominance in several sectors including nutrition, cardiac rhythm"
2025-05-23,Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?,Yahoo,"With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside."
2025-05-23,Sequel Med Tech to Integrate Twiist Automated Insulin Delivery System with Abbott's Future Dual Glucose-Ketone Sensor,Finnhub,"Sequel Med Tech, LLC announced a commercial development agreement for future integration of Sequel's twiist Automated Insulin Delivery System powered by Tidepool, with Abbott's glucose-ketone sensor,..."
2025-05-24,Abbott (ABT) Stock Moves -0.15%: What You Should Know,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $131.30, denoting a -0.15% change from the preceding trading day."
2025-05-24,Abbott Laboratories (NYSE:ABT) Collaborates On Advanced Diabetes Management With Glucose-Ketone Sensor Integration,Yahoo,"Abbott Laboratories (NYSE:ABT) made headlines with its commercial development agreement to integrate advanced diabetes management technology with Sequel Med Tech, aiming to improve outcomes for individuals with type 1 diabetes. Over the past month, Abbott's on-market total shareholder returns remained flat, reflecting broader market trends influenced by ongoing global trade tensions. Despite the market's 1.4% decline during the same period, Abbott's announcements, including partnerships and..."
2025-05-25,"If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?",Yahoo,"Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells healthcare products worldwide. If You Bought Abbott Laboratories Stock 10 Years Ago The company's stock traded at approximately $49.14 per share 10 years ago. If you had ..."
2025-05-26,Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & Supplies - Diversified Pack,Yahoo,Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.
2025-05-27,"Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery",Yahoo,"Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This life-changing therapy is available for patients whose mitral valves are not functioning properly due to severe mitral annular calcification (MAC), a buildup of calcium within the ring-like structure (known as an annulus) that supports the mitral valve."
2025-05-27,A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT),Yahoo,Key Insights Abbott Laboratories' estimated fair value is US$125 based on 2 Stage Free Cash Flow to Equity With US$131...
2025-05-27,Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story,SeekingAlpha,"Abbott's steady cash flow, premium margins, and expanding diabetes and medtech franchises make it a long-term winner. See why ABT stock is a Buy."
2025-05-28,"How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott",Yahoo,Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.
2025-05-28,Abbott Stock Gains Following FDA Approval of the Tendyne System,Yahoo,"ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC."
2025-05-28,"The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories and AT&T",Yahoo,"Coca-Cola, Abbott and AT&T shine in Zacks' latest reports, with each outperforming peers year-to-date despite headwinds in key segments."
2025-05-28,Carillon Eagle Growth & Income Fund Q1 2025 Commentary,SeekingAlpha,"The S&P 500 Index concluded the first quarter down 4.3%, marking a turbulent start to 2025 following two years of robust gains."
2025-05-28,"Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio",Yahoo,"Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) system, the first device of its kind approved in the US to treat mitral valve disease without open-heart surgery. Tendyne is specifically designed for patients who are not suitable candidates for surgical valve repair or replacement. The product perfectly […]"
2025-05-28,Best Dividend Aristocrats For June 2025,SeekingAlpha,"Investors should focus on Aristocrats with strong dividend growth, undervaluation, and high expected returns, but conduct their own due diligence. See more here."
2025-05-28,"Top Stock Reports for Coca-Cola, Abbott & AT&T",Yahoo,"Coca-Cola, Abbott, and AT&T beat peers YTD with strong earnings, innovation, and strategic moves, but face headwinds from FX, costs, and competition."
2025-05-29,Madison Covered Call & Equity Income Fund Q1 2025 Investment Strategy Letter,SeekingAlpha,"Over the full quarter, the S&P 500 lost 4.3% while the CBOE S&P 500 Buy-Write Index fell 3.1%. The Fund (class Y) outperformed both benchmarks, posting a 1.9% decline."
2025-05-29,Abbott Laboratories (NYSE:ABT) Gains FDA Nod For Tendyne Mitral Valve System,Yahoo,"Abbott Laboratories (NYSE:ABT) recently received FDA approval for its Tendyne™ TMVR system, a significant milestone enhancing its cardiovascular product portfolio. Over the past month, Abbott's stock price moved up by about 3%, which aligns with broader market trends, suggesting that its advancements may have supported this momentum. Alongside this, updates on partnerships and product innovations, such as integrating glucose monitoring data with Epic's health records and collaborating with..."
2025-05-30,"Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds",Yahoo,"ABT sees a 21.6% jump in CGM sales and growing global diagnostics demand, while FX and macro pressure temper its outlook."
2025-05-30,Abbott (ABT) Rises Higher Than Market: Key Facts,Yahoo,"Abbott (ABT) closed the most recent trading day at $132.85, moving +0.63% from the previous trading session."
2025-06-01,There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital,Yahoo,"If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see..."
2025-06-01,"How The BLSH Portfolio Buys Low And Sells High, Consistently",SeekingAlpha,The BLSH strategy systematically buys blue-chip stocks at undervalued prices and sells partial positions at overvalued levels. Learn more about the strategy here.
2025-06-02,Lord Abbett Affiliated Fund Q1 2025 Commentary,SeekingAlpha,"The Fund returned 0.49% reflecting performance at the net asset value of Class I shares with all distributions reinvested for the quarter ended March 31, 2025."
2025-06-03,Media Groups Probed by FTC Over Allegedly Coordinating Boycotts,Yahoo,"(Bloomberg) -- The US Federal Trade Commission is investigating whether more than a dozen media and advertising groups have illegally colluded to boycott online content alleged to be hateful, false or misleading, according to people familiar with the matter and a document seen by Bloomberg News.Most Read from BloombergWhere the Wild Children’s Museums AreBillionaire Steve Cohen Wants NY to Expand Taxpayer-Backed FerryThe Economic Benefits of Paying Workers to MoveAt London’s New Design Museum, V"
2025-06-04,Emerging Markets Power Boston Scientific: Will the Growth Trend Continue?,Yahoo,"BSX posts solid Q1 sales growth in emerging markets, reinforcing their role in the company's long-term global strategy."
2025-06-05,Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?,Yahoo,"Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?"
2025-06-05,Diamond Hill Select Strategy Q1 2025 Commentary,SeekingAlpha,"Markets were mixed in Q1 as the new presidential administration made repeated waves with an avalanche of activity, which left markets uncertain of the likely path forward."
2025-06-05,Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note,Yahoo,"Abbott (ABT) closed at $132.96 in the latest trading session, marking a -0.56% move from the prior day."
2025-06-06,Harbor Long-Term Growers ETF Q1 2025 Commentary,SeekingAlpha,"During Q1, the Harbor Long Term Growers ETF returned -10.09% (at NAV), underperforming the benchmark, the Russell 1000Â® Growth Index, which returned -9.97%."
2025-06-07,"Omada Health goes public at $23 per share, marking second major digital health IPO in 2025",Yahoo,"Omada Health went public on the Nasdaq Friday, marking the second major digital health company to do so after a post-pandemic drought."
2025-06-07,Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?,MarketWatch,Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?
2025-06-09,1 Mooning  Stock with Exciting Potential and 2 to Think Twice About,Yahoo,"Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions."
2025-06-10,3 Low-Volatility Stocks in Hot Water,Yahoo,"A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere."
2025-06-11,5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off,Yahoo,Steady growth and dividend increases over decades can make investors remarkably wealthy.
2025-06-12,Understanding XLV: A Sector ETF Focused On U.S. Healthcare Giants,SeekingAlpha,The Healthcare Select Sector SPDR Fund ETF is a sector ETF offering exposure to large-cap U.S. healthcare companies. Learn more about XLV here.
2025-06-12,Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions,Yahoo,"Tandem Diabetes Care, Inc. recently announced a significant collaboration with Abbott Laboratories (NYSE:ABT) to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem’s insulin delivery systems. This and other collaborations, such as the agreement with Sequel Med Tech, align with Abbott's strategic focus on enhancing diabetes care. Abbott's shares rose 3% over the last quarter, aligning closely with broader market trends, which advanced 13% over the past year. The company's..."
2025-06-13,Abbott Declares 406th Consecutive Quarterly Dividend,Yahoo,The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
2025-06-13,"Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025",Finnhub,"The board of directors of Abbott declared a quarterly common dividend of 59 cents per share. The cash dividend is payable Aug. 15, 2025, to shareholders of record at the close of business on July 15,..."
2025-06-13,Abbott Laboratories Stock Sees RS Rating Rise To 82,Yahoo,"On Thursday, Abbott Laboratories stock earned a positive adjustment to its Relative Strength (RS) Rating, from 78 to 82. The medical device firm recently announced a collaboration with Tandem Diabetes Care to develop automated insulin delivery systems using a dual glucose-ketone sensor."
2025-06-16,Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings,Yahoo,"Investing.com -- Leerink Partners began coverage on three of the largest medical technology companies on Monday, assigning bullish ratings to Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT), while taking a more neutral stance on Abbott Laboratories (NYSE:ABT)"
2025-06-16,Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions,Yahoo,"Abbott (NYSE: ABT) announced today that Health Canada has approved the company's i-STAT TBI test cartridge for use with whole blood, helping clinicians to assess suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes. Previously, the tests used to help assess mild traumatic brain injury (mTBI) were only authorized for use with plasma or serum, requiring samples to be sent to a lab for processing."
2025-06-16,Abbott Declares 406th Consecutive Quarterly Dividend,Finnhub,"ABBOTT PARK, Ill. - The board of directors of Abbott today declared a quarterly common dividend of 59 cents per share.This marks the 406th consecutive quarterly dividend to be paid by Abbott since..."
2025-06-16,1 Unpopular Stock that Should Get More Attention and 2 to Avoid,Yahoo,Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
2025-06-17,"Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management",Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc. (NASDAQ:TNDM) announced a new agreement with Abbott to develop and commercialize integrated diabetes solutions. The collaboration will combine Abbott’s future dual glucose-ketone sensor with Tandem’s innovative insulin delivery systems, with the aim of providing […]"
2025-06-17,"Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?",Yahoo,"Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors wondering how to approach the situation."
2025-06-17,Abbott (ABT) Stock Dips While Market Gains: Key Facts,Yahoo,"In the most recent trading session, Abbott (ABT) closed at $134.01, indicating a -1.19% shift from the previous trading day."
2025-06-18,"Esker Expands European Field Presence with New Office in Ghent, Belgium",Yahoo,"Press Release Esker Expands European Field Presence with New Office in Ghent, Belgium LYON, France, and MIDDLETON, Wis. — June 18, 2025 — Esker, a global cloud platform and leader in AI-driven process automation solutions for finance and customer service functions, is proud to announce the opening of its new office in Ghent, Belgium, further strengthening its presence in the Benelux region (Belgium, the Netherlands and Luxembourg).The new Ghent office will enable Esker to better serve its growin"
2025-06-18,Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?,Yahoo,Sector ETF report for PJP
2025-06-18,Leerink Partners Begins Coverage on ABT,Yahoo,"Abbott Laboratories (NYSE:ABT) is one of Best Dividend Stocks to Buy for Dependable Growth. The company is a Dividend King with 53 consecutive years of dividend growth. Its five-year average annual dividend growth rate sits at nearly 11%. It pays a quarterly dividend of $0.59 per share and has a dividend yield of 1.78%, as […]"
2025-06-18,3 Dividend Growth Stocks To Buy and Hold Forever,Yahoo,"These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income."
2025-06-19,ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?,Yahoo,"Abbott gains Health Canada approval for its i-STAT TBI test, enabling rapid bedside concussion detection via whole blood."
2025-06-19,Abbott Laboratories (NYSE:ABT) is a favorite amongst institutional investors who own 81%,Yahoo,Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...
2025-06-19,Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor,Yahoo,"IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's future dual glucose-ketone sensor in the U.S. The iLet represents a significant advancement in diabetes care as the first and only AID system that makes 100% of insulin dosing decisions automatically. With the iLet, people living wi"
2025-06-20,DXCM's Access Gains and Operational Strength Offset Margin Pressures,Yahoo,"DXCM rides on record patient growth and T2D access gains, but margin pressure and FDA scrutiny cloud the outlook."
2025-06-20,Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States,Yahoo,"SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor. The Company has initiated an early access program in the United States (U.S.), and intends to scale availability in the second half of 2025."
2025-06-20,5 things to watch at the ADA’s Scientific Sessions,Yahoo,"The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices."
2025-06-20,The Department of Health - Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi,Finnhub,"During BIO International Convention in Boston USA, the Department of Health - Abu Dhabi , the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a..."
2025-06-21,New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier,Yahoo,"Late-breaking research presented at the American Diabetes Association's 85th Scientific Sessions showed that Abbott's (NYSE: ABT) Healthy Food Rx ""food is medicine"" program helped people living with diabetes to eat better and feel healthier, with participants reporting improved diet quality and health status."
2025-06-21,"Top Research Reports for Meta Platforms, Palantir & Abbott",Yahoo,"META, PLTR, and ABT lead today's top research picks, with strong AI momentum, product innovation, and expanding market share."
2025-06-21,Abbott Laboratories (NYSE:ABT) Enhances Diabetes Care And Partners With Abu Dhabi For Pharma Expansion,Yahoo,"Recent events for Abbott Laboratories (NYSE:ABT) include the integration of Beta Bionics' iLet Bionic Pancreas with Abbott's sensor technology and a partnership with the Department of Health - Abu Dhabi, aiming to localize pharmaceutical manufacturing. Additional FDA approvals for key products and a declared dividend highlight the company's operational momentum. Despite these developments, the broader market impact included mixed U.S. stock performance and geopolitical tensions affecting..."
2025-06-21,Abbott Laboratories : 2024 GLOBAL SUSTAINABILITY REPORT,Finnhub,GLOBAL SUSTAINABILITY REPORT 2024 ...
2025-06-23,BBNX Stock May Gain From Abbott Deal to Advance iLet Integration,Yahoo,"Beta Bionics collaborates with Abbott to integrate its iLet system with a dual sensor, aiming to simplify and enhance diabetes care."
2025-06-23,TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 +,Yahoo,Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
2025-06-23,New Research on Abbott's Healthy Food Rx Program Shows Food is Medicine Approach Helps People Living with Diabetes Eat Better and Feel Healthier,Finnhub,CHICAGO - Late-breaking research presented at the American Diabetes Association's 85th Scientific Sessions showed that Abbott's Healthy Food Rx 'food is medicine' program helped people living with...
2025-06-23,"The Zacks Analyst Blog Highlights Meta, Palantir, Abbott Laboratories, SandRidge and CompX",Yahoo,"META, PLTR and ABT lead this week's Zacks blog as AI growth, strong pipelines and solid earnings drive investor interest."
2025-06-24,Should You Continue to Retain Abbott Stock in Your Portfolio Now?,Yahoo,"ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead."
2025-06-24,3 Dirt-Cheap Dividend Aristocrats About to Explode Higher,Yahoo,"These buy-rated Dividend Aristocrats are trading at rare discounts, offering strong yields, bullish ratings, and potential long-term upside."
2025-06-24,Is Abbott Laboratories' (NYSE:ABT) Stock's Recent Performance A Reflection Of Its Financial Health?,Yahoo,Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 5.3% over the past three...
2025-06-24,"ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors",Yahoo,"Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors."
2025-06-25,"Tandem’s Elizabeth Gasser on patch pump plans, Abbott partnership",Yahoo,The strategy and product exec said Tandem aims to give patients options and reach more people who haven’t yet used insulin pumps.
2025-06-26,NVST vs. ABT: Which Stock Is the Better Value Option?,Yahoo,NVST vs. ABT: Which Stock Is the Better Value Option?
2025-06-26,Abbott Hosts Conference Call for Second-Quarter Earnings,Yahoo,"Abbott (NYSE: ABT) will announce its second-quarter 2025 financial results on Thursday, July 17, before the market opens."
2025-06-26,Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever,Yahoo,"Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them."
2025-06-26,Oppenheimer Sees Strong Upside for Abbott (ABT) with Volt System and Diabetes Innovation,Yahoo,"Abbott Laboratories (NYSE:ABT) ranks among the top stocks for an early retirement portfolio. On June 18, Oppenheimer reaffirmed its $140 price target and Outperform rating on Abbott Laboratories (NYSE:ABT), noting growing confidence in the company’s Volt system and future glucose-ketone monitoring technology. Following the observation of live PFA (pulsed field ablation) case viewings of rival […]"
2025-06-26,John Paul Mitchell Systems joins companies moving headquarters to Texas from California,Yahoo,Gov. Abbott announced the major hair care company will relocate to Wilmer and create 80 new jobs.
2025-06-26,Diabetes stocks rally after RFK comments on HHS campaign,Yahoo,"Sarah Karlin-Smith of Pink Sheet reported via X: “RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). His vision is every American wearing “wearable” in 4 years.” Shares of companies in the continuous glucose monitoring space moved higher intraday, including Tandem Diabetes (TNDM), DexCom (DXCM), Insulet (PODD), Abbott (ABT) and Medtronic (MDT). Published first on TheFly – the ultimate source for real-time, m"
2025-06-27,Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $133.67, denoting a -2.71% move from the preceding trading day."
2025-06-27,Governor announces first Texas Energy Fund loan for 122 MW natural gas facility,Yahoo,"""Under the loan agreement, subject to customary financial closing procedures, total project costs are not to exceed $175 million, with the PUC providing a 20-year TEF loan of up to $105 million at a 3% interest rate,"" said a press release on Abbott's official website.  The governor's office added that the Kerrville Public Utility Board is the project's sponsor and will develop the facility, which is projected to begin operations by 2027."
2025-06-28,Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT),Yahoo,Key Insights Abbott Laboratories' estimated fair value is US$129 based on 2 Stage Free Cash Flow to Equity Abbott...
2025-06-28,Got $500? 2 Healthcare Stocks to Buy and Hold Forever,Yahoo,"Abbott Laboratories provides exposure to multiple areas of healthcare.  The healthcare sector is an ideal place for long-term investors to focus their attention, in my view.  You won't need a fortune to get started investing in the healthcare sector."
2025-06-28,Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum,Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the Best Dividend Stocks of 2025. In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite challenging conditions driven by tariffs. The company exceeded Wall Street expectations across its three key profitability metrics: earnings per share, adjusted gross margin, […]"
2025-06-30,Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks,Yahoo,"During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 105 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up"
2025-06-30,"Abbott Labs: Proactive, Adaptive, Solid",SeekingAlpha,"Abbott remains a solid, strategic healthcare holding for investors. Read why this company is well positioned for steady growth."
2025-06-30,New CGM pump expands market reach and clinical utility,Yahoo,"The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent insulin dosing."
2025-06-30,What to Expect From Abbott Laboratories' Q2 2025 Earnings Report,Yahoo,"Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth."
2025-06-30,Advanced Bitcoin Technologies Reports Full Year 2024 Earnings,Yahoo,Advanced Bitcoin Technologies ( DUSE:ABT ) Full Year 2024 Results Key Financial Results Net loss: €289.4k (loss...
2025-07-01,2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love,Yahoo,Policies associated with the MAHA movement could boost these two stocks significantly.
2025-07-01,Here's What to Expect From HCA Healthcare's Next Earnings Report,Yahoo,"HCA Healthcare is poised to release its second-quarter results later this month, and analysts project a double-digit earnings growth."
2025-07-01,Who benefits from over-the-counter CGMs?,Yahoo,"Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for adults without diabetes."
2025-07-02,"Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion",Yahoo,"ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts."
2025-07-02,Are Medical Stocks Lagging  Amarin (AMRN) This Year?,Yahoo,Here is how Amarin (AMRN) and Abbott (ABT) have performed compared to their sector so far this year.
2025-07-02,"Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern",Yahoo,"HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds."
2025-07-02,Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital,Yahoo,"If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an..."
2025-07-02,"How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts",Yahoo,"The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on diabetes devices."
2025-07-02,"Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids",Yahoo,"Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech."
2025-07-03,Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings,Yahoo,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
2025-07-03,Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day."
2025-07-03,Abbott (ABT) Upgraded to Buy: Here's What You Should Know,Yahoo,"Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)."
2025-07-04,Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?,Yahoo,"According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?"
2025-07-04,Japan Tissue Diagnostics Market to Hit US$ 234 Million by 2030 | Aging Population Spurs Demand for Advanced Tissue Diagnostics in Japan,Yahoo,"The Japanese tissue diagnostics market is projected to climb to US$ 234 Million by 2030, driven by aging demographics and increasing prevalence of chronic diseases. Key market innovations include digital pathology and growing use of automated systems. Major players include Abbott and Sakura Finetek Japan.Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The ""Japan IVD Tissue Diagnostics Market (By Segment - Pre-Analytical Processing, H&E Staining, Special Staining, IHC Staining, ISH Staining, Digital Pa"
2025-07-04,"Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas",Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US. The collaboration aims to enhance real-time decision-making support for individuals with diabetes. […]"
2025-07-06,2 Dividend Stocks to Buy for Decades of Passive Income,Yahoo,"Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings.  In 2013, AbbVie (NYSE: ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (NYSE: ABT).  AbbVie is a pharmaceutical leader with a large portfolio of approved products, none more important than a duo of immunology medicines: Skyrizi and Rinvoq."
2025-07-06,Abbott Laboratories (NYSE:ABT) shareholders have earned a 9.6% CAGR over the last five years,Yahoo,"The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up..."
2025-07-07,Should You Retain Henry Schein Stock in Your Portfolio Right Now?,Yahoo,"Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges."
2025-07-07,Absci Appoints Biopharma Leader Mary Szela to Board of Directors,Yahoo,"Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertiseVANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the appointment of veteran biopharmaceutical executive Mary Szela to its Board of Directors. With decades of R&D and commercial leadership experience, Ms. Sze"
2025-07-08,Is Hologic Stock's Low Valuation an Opportunity or a Value Trap?,Yahoo,"HOLX trades below peers on P/S, but falling EPS, weak Breast Health sales and China risks cloud the outlook."
2025-07-08,Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada,Yahoo,"Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes. This innovative product features the world's smallest1,2 glucose sensor."
2025-07-09,Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT),Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at Oppenheimer reiterated an ‘Outperform’ rating on the stock and a $14 price target. The bullish stance follows the Centers for Medicare & Medicaid Services (CMS) final decision on transcatheter edge-to-edge repair for the […]"
2025-07-09,These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar,Yahoo,The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
2025-07-09,Alcon Stock Gains Following UNITY VCS' Approval in Canada,Yahoo,"ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology."
2025-07-09,Biomarkers Market Research Report 2025-2030 | Assay Kit Demand Surges as Advancements in Omics Technologies Elevate Biomarker Discovery and Diagnostic Precision,Yahoo,"The biomarkers market is poised to grow from USD 62.39 billion in 2025 to USD 104.15 billion by 2030, with a CAGR of 10.8%. This growth is driven by the advantages of assay kits and advancements in genomics, proteomics, and next-generation sequencing, leading to novel biomarker development. Predictive biomarkers are dominant in efficacy biomarkers due to their role in guiding treatment decisions, particularly in oncology and autoimmune diseases. The immunoassays segment led the market in 2024, s"
2025-07-09,DexCom Is Doubling Down on Its ‘Mistake.’ Why It’s Time to Buy the Stock.,Yahoo,DexCom’s decision to pursue the Type 2 diabetes market wasn’t faulty. It was management’s execution of its strategy that caused the problem.
2025-07-10,Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Yahoo,Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2025-07-10,ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?,Yahoo,"Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor."
2025-07-10,Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?,Yahoo,BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.
2025-07-10,Abbott gains national CMS coverage for tricuspid valve repair,Yahoo,"The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid regurgitation, in which blood can leak backward into the heart."
2025-07-10,Abbott Laboratories (NYSE:ABT) Expands Diabetes Care with FreeStyle Libre 3 Plus Launch in Canada,Yahoo,"Abbott Laboratories (NYSE:ABT) recently introduced the FreeStyle Libre 3 Plus in Canada, marking an advancement in diabetes management technology with its small, sensor-based glucose monitoring system. This development, alongside other approvals and partnerships like the i-STAT TBI test and mitral valve replacement system, may have bolstered investor confidence contributing to the company's quarterly share price growth of almost 5%. However, against a backdrop of generally rising market..."
2025-07-11,Smart Money Going in Senior Health: Key Stocks in Elderly Care,Yahoo,"RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand."
2025-07-11,"Stocks to watch next week: Goldman Sachs, Netflix, TSMC, ASML and Burberry",Yahoo,Earnings preview of key companies reporting in the coming week and what to look out for.
2025-07-11,VIVO Agency Names Jennifer Mugnaini as EVP of Client Services,Yahoo,"VIVO Agency, a strategic marketing partner for MedTech and healthcare brands, today announced the appointment of Jennifer Mugnaini as EVP of Client Services. Jen has over two decades of experience in healthcare marketing and client leadership, and will oversee VIVO's client service teams, shaping the agency's delivery model to meet the evolving needs of today's most ambitious health brands."
2025-07-12,"Core CPI In Focus With JPMorgan, Goldman, Netflix Set To Report Earnings",SeekingAlpha,"This week witnesses earnings from banking giants like JPM, WFC, BAC, BLK. Investors may also look at Core CPI and Core PPI on Tuesday and Wednesday."
2025-07-12,Just How Bad Is the Art Market’s Case of the Blues?,Yahoo,"Two art-market analysts find a bear market for auctions sales of art: For three seasons now, 50% of artworks resold at auction had negative returns, the worst market this century."
2025-07-12,Abbott (ABT) Suffers a Larger Drop Than the General Market: Key Insights,Yahoo,"Abbott (ABT) reached $132.02 at the closing of the latest trading day, reflecting a -1.18% change compared to its last close."
2025-07-12,"Dividend Champion, Contender, And Challenger Highlights: Week Of July 13",SeekingAlpha,"Read our weekly summary for companies which changed their dividends, stocks with upcoming ex-dividend dates, and companies with upcoming pay dates."
2025-07-13,Wall Street Brunch: Big Banks Kick Off Earnings Season,SeekingAlpha,Big banks and Netflix to report as Q2 reporting heats up. June CPI seen rising. Amazon sees biggest Prime Day 
2025-07-13,"Inflation data, big bank earnings, and Netflix results: What to watch this week",Yahoo,"A busy week ahead for investors will see inflation data, the debate about the Fed's next move, and the start of second quarter earnings season all come into focus after a flurry of trade activity last week."
2025-07-13,Here's Why We Think Abbott Laboratories (NYSE:ABT) Is Well Worth Watching,Yahoo,"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story..."
2025-07-13,Wall Street Week Ahead,SeekingAlpha,"Get insights into Q2 earnings season, market trends, and economic indicators like inflation and retail sales. Stay ahead with exclusive analysis."
2025-07-14,Countdown to Abbott (ABT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS,Yahoo,"Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025."
2025-07-14,ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus,Yahoo,"Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments."
2025-07-14,"Stocks Decline Pre-Bell Amid Tariff Tensions; Investors Await Inflation Data, Earnings",Yahoo,The benchmark US stock measures were pointing lower before the opening bell Monday as investors asse
2025-07-14,"Tariffs, Earnings Season Blunt Wall Street Pre-Bell; Asia Mixed, Europe Off",Yahoo,Wall Street futures pointed moderately lower pre-bell Monday as traders weighed weekend social-media
2025-07-14,"Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships",Yahoo,"Explore the Global Prostate Care Market's growth, projected to reach USD 69.91 billion by 2031, driven by demographic shifts, tech advances, and the rising incidence of prostate conditions. Key players like Medtronic and Johnson & Johnson lead with product innovation. This report analyzes market trends by treatment, disease type, and region.Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The ""Prostate Care Market (2025 Edition): Analysis By Treatment Type (Medications, Surgical Treatments, Minimally I"
2025-07-15,"Netflix, Goldman Sachs, J&J: Earnings to Watch This Week",Yahoo,"Earnings season takes off this week led by U.S. banks. JPMorgan Chase, Goldman Sachs and others. Big non-financial companies including Johnson & Johnson, Netflix and PepsiCo are also on the way. Here are the highlights of who is reporting, and the expected approximate release times."
2025-07-15,Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?,Yahoo,"BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions."
2025-07-15,Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity,Yahoo,"Artificial Intelligence (AI) algorithms are revolutionizing the way retina images are analyzed for detecting conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. These advanced algorithms often achieve diagnostic accuracies that equal or surpass human experts, especially in complex cases. This capability not only enhances diagnostic precision but also supports clinicians in delivering more effective treatment strategies. AI systems that analyze retina images can sp"
2025-07-15,Nasdaq Reaches New High as Investors Brush Off Tariff Concerns,Yahoo,"US equities moved higher Monday, lifting the Nasdaq Composite to a new all-time high as traders appe"
2025-07-15,Equity Markets Rise Intraday as Investors Track Tariff Updates,Yahoo,US benchmark equity indexes were higher after midday Monday as markets tracked updates on trade deve
2025-07-16,"Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific",Yahoo,"Saudi Arabia's in-vitro diagnostics market is set to grow from USD 734.7M in 2024 to USD 932.3M by 2030, driven by a rising elderly population and chronic disease prevalence. Saudi Arabia leads the GCC region in IVD, benefiting from government initiatives like Vision 2030 and healthcare sector advances.Dublin, July 16, 2025 (GLOBE NEWSWIRE) -- The ""Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Segment, Application, Product, End User), Size, Share, Major Deals, Key Company Profiles, Revenue,"
2025-07-16,"Netflix, PepsiCo, J&J: Earnings to Come This Week",Yahoo,"Earnings season continues Wednesday with Bank of America, Goldman Sachs and others on the way. Big non-financial companies coming up include Johnson & Johnson, followed Thursday by Netflix and PepsiCo."
2025-07-16,Jim Cramer on Abbott: “Patience is a Virtue With ABT”,Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shared insights on. While discussing the stock, Cramer recommended patience, as he commented: “Then one of my absolute favorite companies, medical device maker, Abbott Labs reports. And you know, I always like to tell you which companies tend to be misinterpreted in a negative […]"
2025-07-16,Abbott Laboratories (ABT) Q2 Earnings: What To Expect,Yahoo,Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday morning. Here’s what investors should know.
2025-07-16,"3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS",Yahoo,"The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports."
2025-07-17,Abbott Earnings Beat Forecasts. Why the Stock Is Having Its Worst Day Since 2021.,Yahoo,Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.
2025-07-17,Abbott Narrows Its Outlook as COVID-19 Testing Demand Wanes. Its Stock Is Falling.,Yahoo,"Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than-expected quarterly results, as demand for COVID-19 tests declines."
2025-07-17,Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat,Yahoo,"ABT beats on Q2 earnings and revenues with double-digit growth in Medical Devices, yet shares fall 5% pre-market."
2025-07-17,"These Stocks Are Moving the Most Today: Lucid, TSMC, United, Sarepta, PepsiCo, Abbott Labs, MP Materials, Archer Daniels, and More",Yahoo,"Lucid soars after announcing a self-driving partnership with Uber Technologies and Nuro, Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, and PepsiCo’s adjusted earnings top forecasts."
2025-07-17,Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors,Yahoo,"Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year. The company reported second-quarter sales of $11.14 billion, beating the consensus of $11.07 billion. Second-quarter sales increased 7.4% on a reported basis, 6.9% on an organic basis, or 7.5% when excluding COVID-19 testing-related sales. Also Read: Elevance Health Hit"
2025-07-17,Abbott Issues Downbeat Third-Quarter Earnings Outlook; Narrows Full-Year Profit Guidance,Yahoo,Abbott Laboratories (ABT) issued a third-quarter earnings outlook below market estimates on Thursday
2025-07-17,"GE Aerospace, Abbott Labs, Elevance: Trending Tickers",Yahoo,"GE Aerospace (GE) stock pops after reporting a strong second quarter and raising its full-year outlook. Abbott Laboratories (ABT) narrows its full-year outlook despite in-line earnings as Trump threatens tariffs on the pharmaceutical industry. Elevance (ELV) lowers its full-year profit outlook as higher costs associated with changing government plans weigh on insurers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here."
2025-07-17,Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript,SeekingAlpha,"Abbott Laboratories (NYSE:ABT) Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of Investor..."
2025-07-17,Abbott Laboratories Sheds Nearly 6% On A Rare Guidance Miss,Yahoo,"Abbott stock toppled early Thursday after the health giant issued a light organic sales outlook for 2025, though it beat quarterly estimates."
2025-07-17,Abbott (ABT) Reports Q2 Earnings: What Key Metrics Have to Say,Yahoo,"Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers."
2025-07-17,Abbott (ABT) Q2 Earnings and Revenues Top Estimates,Yahoo,"Abbott (ABT) delivered earnings and revenue surprises of +0.80% and +0.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?"
2025-07-17,Abbott’s Q2 revenue tops expectations but shares fall,Yahoo,"Investing.com -- Abbott Laboratories reported second-quarter earnings that slightly exceeded analyst expectations, but shares fell 2.5% following the results."
2025-07-17,"Abbott Labs Pares Outlook After Profit, Sales Gains",Yahoo,The healthcare-products maker trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in the second quarter.
2025-07-17,"Abbott lowers sales forecast on diagnostics decline, US funding cuts",Yahoo,"Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices."
2025-07-17,Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates,Yahoo,"Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates."
2025-07-17,Abbott: Q2 Earnings Snapshot,Yahoo,"The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.25 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.14 billion in the period, which also beat Street forecasts."
2025-07-17,"Abbott profit forecast falls short, ramps up US investing amid tariff pressure",Yahoo,"(Reuters) -Abbott on Thursday forecast third-quarter profit below Wall Street expectations and estimated about $200 million in annual tariff costs.  The medical device maker's shares slid 8%, even as it announced a new plant in the U.S. to mitigate the hit from President Donald Trump's sweeping duties on trading partners.  Speaking on a post-earnings call, Chief Financial Officer Phil Boudreau said the impact of tariffs will likely be felt in the second half of the year, as the company works its way through its inventory."
2025-07-17,Abbott Reports Second-Quarter 2025 Results,Yahoo,"Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2025."
2025-07-17,Stocks Mostly Up Pre-Bell as Trump Denies Speculation About Firing Fed Chair Powell; Corporate Earnings on Deck,Yahoo,US equity markets were mostly pointing higher before the opening bell Thursday as President Donald T
2025-07-17,Abbott Laboratories (NYSE:ABT) Has A Rock Solid Balance Sheet,Yahoo,"Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously..."
2025-07-17,Abbott Labs: Q2 EPS up 10%,Finnhub,"Abbott Laboratories has reported Q2 2025 adjusted EPS that is up over 10% to $1.26, actually missing the consensus, with an adjusted operating margin of 22.9%, up 100bp.At over $11.1bn, the healthcare..."
2025-07-17,"Abbott Labs Pares Outlook, Logs 2Q Profit Gains",MarketWatch,"Abbott Labs Pares Outlook, Logs 2Q Profit Gains"
2025-07-17,"Netflix Earnings, Consumer Sentiment, Retail Sales: Still to Come This Week",Yahoo,"The earnings calendar turns to big consumer names, after banks provided the highlights earlier this week. GE Aerospace, PepsiCo and Netflix are among companies reporting results Thursday, in the first big week of earnings season."
2025-07-18,Stocks Pressured by Weakness in Netflix and Health Insurers,Yahoo,"The S&P 500 Index ($SPX ) (SPY ) today down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. September E-mini S&P futures (ESU25 ) are down -0.14%, and September E-mini Nasdaq futures (NQU25..."
2025-07-18,Abbott Laboratories (ABT) Drops on Lower Full-Year Guidance,Yahoo,"We recently published These 10 Stocks Just Lost Their Spark. Abbott Laboratories (NYSE:ABT) is one of the worst-performing companies on Thursday. Abbott Laboratories declined by 8.52 percent on Thursday to end at $120.51 apiece as investors were disheartened by the lowering of its full-year guidance. For the full year, Abbott Laboratories (NYSE:ABT) now projects organic […]"
2025-07-18,"Stock Market News for Jul 18, 2025",Yahoo,"U.S. stocks ended higher on Thursday, with the S&P 500 and the Nasdaq closing at new record highs, as fresh economic data and solid earnings from a slew of big companies bolstered investors' faith in the economy."
2025-07-18,Are Medical Stocks Lagging  Abbott Laboratories (ABT) This Year?,Yahoo,Here is how Abbott (ABT) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
2025-07-18,"Snowflake initiated, Chipotle upgraded: Wall Street's top analyst calls",Yahoo,"Snowflake initiated, Chipotle upgraded: Wall Street's top analyst calls"
2025-07-18,"Down 9.0% in 4 Weeks, Here's Why Abbott (ABT) Looks Ripe for a Turnaround",Yahoo,"Abbott (ABT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term."
2025-07-18,"Abbott upgraded after post-earnings selloff, hardware drag seen temporary",Yahoo,"Investing.com -- Jefferies upgraded Abbott Laboratories (NYSE:ABT) to Buy from Hold, calling the market reaction to the company’s latest results “too punitive” and arguing that near-term headwinds in diagnostics are likely to ease."
2025-07-18,Here's What to Expect From Charles River Laboratories' Next Earnings Report,Yahoo,"Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure."
2025-07-18,Abbott Laboratories: What's Behind The Q2 Earnings Slump?,SeekingAlpha,"Abbott Laboratories' second-largest division, diagnostics, continues to be a hindrance, while the FY group operating margin guidance was cut. Learn more on ABT stock here."
2025-07-18,Abbott Laboratories (ABT) Q2 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...,Yahoo,"Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds in diagnostics and international markets."
2025-07-18,"Nasdaq, S&P 500 Clinch Records Amid Fresh Economic Data, Earnings Reports",Yahoo,The Nasdaq Composite and the S&P 500 climbed to new highs on Thursday as Wall Street tracked the lat
2025-07-18,"Equities Rise Intraday as Markets Parse Macro Data, Earnings",Yahoo,US benchmark equity indexes were higher intraday as traders assessed the latest corporate earnings a
2025-07-18,"Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup",MarketWatch,"Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup"
2025-07-18,Why Abbott Laboratories (ABT) Shares Are Plunging Today,Yahoo,"Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but maintained its full-year guidance, which may have disappointed investors hoping for a raised outlook."
2025-07-18,"Biochip Market Global Outlook Report 2025, with Focus on Microarrays and Lab-on-a-Chip",Yahoo,"Discover comprehensive insights into the global biochip market, providing revenue analysis, trends, and forecasts to 2029. Examine segmented data by product type, technology, application, and region, and explore sustainability, ESG developments, and key players like Abbott and Agilent Technologies. Global Biochip Market Market Global Biochip Market Market Dublin, July 17, 2025 (GLOBE NEWSWIRE) -- The ""Biochip Market: Microarrays and Lab-on-a-Chip"" report has been added to ResearchAndMarkets.com'"
2025-07-18,Top Midday Stories: TSMC Lifts 2025 Revenue Growth Guidance; Lucid Partners With Uber on Robotaxi Launch,Yahoo,All three major US stock indexes were up in late-morning trading Thursday as fresh economic data and
2025-07-19,Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations,Yahoo,Abbott Laboratories ( NYSE:ABT ) Second Quarter 2025 Results Key Financial Results Revenue: US$11.1b (up 7.4% from 2Q...
2025-07-19,Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector,Yahoo,"AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AbbVie Inc. (NYSE:ABBV) stands out as a major player in the pharmaceutical industry, with a broad range of approved treatments. Among its most significant offerings are the immunology drugs Skyrizi and Rinvoq, which are expected to contribute to revenue growth […]"
2025-07-19,How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts,Yahoo,"Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Abbott Laboratories (NYSE:ABT) has long held a strong position in the heavily regulated healthcare industry. Over the years, it has earned the trust of both doctors and consumers, making its well-established brands more appealing in the market. In recent […]"
2025-07-21,"Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer",Yahoo,"We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is a healthcare company. While it was one of Cramer’s top stocks for most of this year, this show saw the CNBC TV host take a different tone. […]"
2025-07-21,Drugs of Abuse (DoA) Testing Market Opportunities and Strategies to 2034 | Strategic Acquisitions Boost Market Position of Leading DOA Testing Companies,Yahoo,"The global Drugs of Abuse (DOA) testing market is set to grow from $7.29B in 2024 to $16.98B in 2034, driven by healthcare awareness and demand for accurate tests. With North America leading, key growth regions include Asia-Pacific and Eastern Europe. Major players like Abbott are enhancing market strategies with partnerships and innovations, such as mass spectrometry for improved accuracy. Drugs of Abuse (DoA) Testing Market Drugs of Abuse (DoA) Testing Market Dublin, July 21, 2025 (GLOBE NEWSW"
2025-07-21,"India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher",Yahoo,"The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The ""India In Vitro Diagnostics Market Report and Forecast 2025-2034"" has been added to ResearchAndMarkets.com's offering. The India in vi"
2025-07-21,"Cote d'Ivoire IVD Market Forecast Report 2025-2032 | Opportunities in Public-Private Partnerships, Molecular Diagnostics Demand, Telemedicine and Point-of-Care Testing",Yahoo,"The Côte d’Ivoire IVD market is poised for growth with the increasing prevalence of infectious diseases, government support, and technological advancements in diagnostics. Key players include Abbott, Roche, and Siemens. The market segments by offerings into reagents, instruments, and services, with reagents poised to dominate due to the high rate of infectious diseases like malaria and HIV. By technology, glucose monitoring is expected to see the highest growth due to rising diabetes awareness."
2025-07-21,"Kenya IVD Market Research Report 2025-2032 | Opportunities in Increasing Adoption of Self-testing Kits, Emerging Technologies, Shift Towards Personalized Medicine, Integration of Digital Health",Yahoo,"The Kenya in vitro diagnostics (IVD) market is set for significant growth, driven by a high incidence of infectious diseases like HIV, TB, and malaria, government health initiatives, and increasing demand for quality diagnostics. Key players include Abbott Laboratories, Siemens Healthineers, and Roche. In 2025, the reagents & kits segment is expected to dominate, boosted by the prevalence of infectious and chronic diseases in Kenya. The whole blood glucose monitoring segment is forecasted to exh"
2025-07-22,NVST or ABT: Which Is the Better Value Stock Right Now?,Yahoo,NVST vs. ABT: Which Stock Is the Better Value Option?
2025-07-22,3 Dividend Stocks With 100+ Years of History and Sky-High Growth,Yahoo,"These three century-old companies boast strong buy ratings, 50%+ dividend growth, and rock-solid fundamentals—ideal picks for long-term income investors."
2025-07-22,Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?,Yahoo,"HOLX heads into Q3 earnings with revenue and EPS estimates down, tariff pressures mounting, and stock lagging peers."
2025-07-22,Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales,Yahoo,"Company Continues to Strengthen Organizational Infrastructure with Success-Driven Medical Device Veteran Christina Bailey, VP of Sales, Microbot Medical Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced the appointment of Christina Bailey as its new Vice President of Sales. A two-time"
2025-07-22,Best Dividend Kings: July 2025,SeekingAlpha,Discover why 14 Dividend Kings outperform the S&P 500 in 2025.
2025-07-22,"[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",Yahoo,"[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Labor"
2025-07-23,Jim Cramer Says He “Was Discouraged to Get a Mixed Update from Abbott Labs”,Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company’s recent earnings report results, Cramer said: “Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we’ve long owned for the Charitable Trust… I’d say two […]"
2025-07-23,Institutional owners may ignore Abbott Laboratories' (NYSE:ABT) recent US$10b market cap decline as longer-term profits stay in the green,Yahoo,Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...
2025-07-23,"Tenet Beats Q2 Earnings on Strong Patient Volumes, Hikes '25 EPS View",Yahoo,"THC's Q2 earnings benefit on the back of strong volumes, facility buyouts, higher acuity and favorable payer mix. It currently expects 2025 adjusted EPS within $15.55-$16.21, up from the earlier view of $11.99-$13.12."
2025-07-24,Abbott Laboratories (ABT): A Bull Case Theory,Yahoo,"We came across a bullish thesis on Abbott Laboratories on r/ValueInvesting subreddit by anonymous_sheep1. In this article, we will summarize the bulls’ thesis on ABT. Abbott Laboratories’ share was trading at $120.51 as of July 17th. ABT’s trailing and forward P/E were 15.12 and 23.42, respectively, according to Yahoo Finance. Abbott Laboratories (ABT) delivered quarterly results that […]"
2025-07-24,Hologic's International Momentum Takes Shape: Will Execution Pay Off?,Yahoo,HOLX is leaning into international growth with Surgical division strength and untapped demand driving momentum abroad.
2025-07-24,"The Zacks Analyst Blog Highlights Wells Fargo, Abbott Laboratories, American Express, TSS and Maui Land & Pineapple",Yahoo,"Wells Fargo, Abbott, and American Express lead Zacks highlights, while TSS surges on AI growth and MLP eyes land monetization."
2025-07-24,"Top Stock Reports for Wells Fargo, Abbott & American Express",Yahoo,"Wells Fargo gains post-Fed cap removal, Abbott rides strong devices pipeline, while AmEx sees growth but rising costs pinch margins."
2025-07-25,"Venous Thromboembolism Treatment Devices Market Insights, Competitive Landscape, and Forecast Report 2032 Featuring Abbott, Boston Scientific, AngioDynamics, Argon Medical Devices, and Medtronic",Yahoo,"The Venous Thromboembolism Treatment Devices Market is poised for significant growth, projected to expand at a CAGR of 8.31% from 2025 to 2032. Factors such as rising deep vein thrombosis and pulmonary embolism rates, fueled by aging populations, sedentary lifestyles, and chronic diseases, drive demand. Key market players are innovating with advanced devices, enhancing treatment effectiveness. North America leads the market owing to technological advancements and high disease prevalence. Notable"
2025-07-25,"U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott",Yahoo,"The U.S. acute external ventricular drain market, valued at USD 86.5 million in 2024, is set to grow at a CAGR of 7.9% from 2025 to 2030. Growth is driven by increased demand for noninvasive neurosurgeries, technological innovations, and rising healthcare spending. Favorable reimbursement policies and an aging population further fuel market expansion. U.S. Acute External Ventricular Drain Market U.S. Acute External Ventricular Drain Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The ""U.S. Acut"
2025-07-26,Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity,Yahoo,"Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. The company reported strong earnings in the second quarter of 2025. It posted revenue of $11.1 billion, which showed a 7.37% growth on a YoY basis. The company reported GAAP diluted earnings per share of $1.01, while adjusted diluted […]"
2025-07-26,"HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View",Yahoo,"HCA Healthcare's Q2 earnings rose 24% year over year on stronger patient volumes. EPS for 2025 is expected to be within $25.5-$27, up from the earlier view of $24.05-$25.85."
2025-07-27,Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)?,Yahoo,"It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has..."
2025-07-28,Revvity trims 2025 profit forecast as China policy changes hit diagnostics demand,Yahoo,"(Reuters) -Revvity on Monday lowered its full-year adjusted profit forecast as it expects demand for diagnostics products in its key market China to be hurt by changes to the country's  reimbursement policy, sending the company's shares down nearly 10%.  The medical equipment maker said that it now expects sales of its diagnostics products to grow in the low single digits this year, compared to its previous forecast of mid-single digit growth."
2025-07-28,"Leerink Partners Decreases PT on Abbott Laboratories (ABT) to $136 From $143, Maintains a Hold Rating",Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the top low volatility healthcare stocks to buy now. Analyst Mike Kratky from Leerink Partners reiterated a Hold rating on Abbott Laboratories (NYSE:ABT) on July 21, decreasing the price target to $136.00 from $143.00. The analyst justified the Hold rating with the company’s performance, stating that Abbott Laboratories’ (NYSE:ABT) […]"
2025-07-28,RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT),Yahoo,Abbott Laboratories (NYSE:ABT) ranks among the best low volatility stocks to buy according to analysts. RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott’s strong single-digit revenue and double-digit EPS growth potential as examples of its ability […]
2025-07-28,Best Dividend Aristocrats For August 2025,SeekingAlpha,Dividend Aristocrats are outperforming SPY in July but still trail year-to-date. Check out my Promising Aristocrats list here.
2025-07-28,A Data Deluge Brings a ‘Moment of Truth’ for Markets This Week,Yahoo,"(Bloomberg) -- Wall Street pros are staring down a pivotal week that will likely set the tone for the rest of the year in markets and the economy.Most Read from BloombergThe High Costs of Trump’s ‘Big Beautiful’ New Car Loan DeductionCan This Bridge Ease the Troubled US-Canadian Relationship?Budapest’s Most Historic Site Gets a Controversial RebuildTrump Administration Sues NYC Over Sanctuary City PolicyFirst and foremost is the conclusion of the Federal Reserve’s meeting on Wednesday, and altho"
2025-07-29,A new infant formula seven years in the making is hitting the $2 billion market,Yahoo,Nara Organics will compete with other startup brands like Bobbie.
2025-07-29,"Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott",Yahoo,"The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leadi"
2025-07-29,"North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers",Yahoo,"The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising incidence of autoimmune conditions like rheumatoid arthritis and type 1 diabetes, advancements in diagnostic technologies, and increased healthcare investments. Enhanced diagnostic techniques such as ELISA and next-gen sequencing are improving early detection, with hospitals and clinics expanding sophisticated"
2025-07-29,"Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche",Yahoo,"The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed"
2025-07-29,BME: The Resilient Income Investment Of The Healthcare Industry,SeekingAlpha,"BlackRock Health Sciences Trust offers a resilient 8.63% dividend yield, low expense ratio, and conservative, low-risk positioning. See more on BME ETF here."
2025-07-30,"Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",Yahoo,"The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating"
2025-07-30,IXJ: A Bet On Global Healthcare Recovery,SeekingAlpha,"IXJ offers global healthcare exposure, capturing demographic shifts and innovation trends beyond U.S.-centric ETFs. Read why IXJ ETF is a Buy."
2025-07-30,"Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report",Yahoo,"A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion in 2024, with projections pointing to continued growth through 2029. The twelfth edition of Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition highlights how decentralization of healthcare, rapid innovation, and consumer-driven demand are reshaping how and where diagnostic tests are performed—from traditional clinical settings to homes, workplaces, and remo"
2025-07-31,AbbVie’s (NYSE:ABBV) Q2: Beats On Revenue,Yahoo,"Pharmaceutical company AbbVie (NYSE:ABBV) announced better-than-expected revenue in Q2 CY2025, with sales up 6.6% year on year to $15.42 billion. Its non-GAAP profit of $2.97 per share was 2.1% above analysts’ consensus estimates."
2025-07-31,Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT),Yahoo,Key Insights Abbott Laboratories' estimated fair value is US$133 based on 2 Stage Free Cash Flow to Equity With US$129...
2025-07-31,UBS Shrugs Abbott Laboratories’ (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating,Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty. On July 21, UBS reiterated a ‘Buy’ rating and a $148 price target on the stock. The bullish stance comes on the heels of the stock coming under pressure following the release of lower fiscal year 2025 […]"
2025-08-01,2 Top Stocks to Buy Now If You Want Decades of Passive Income,Yahoo,"These companies have provided strong returns to long-term shareholders, but they aren't done yet."
2025-08-04,Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital,Yahoo,"There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a..."
2025-08-04,Worried About a Stock Market Crash? These Dividend Stocks Can Help You Ride It Out,Yahoo,"Discover four recession-resistant dividend stocks from stable sectors with decades of payout growth, low payout ratios, and strong analyst ratings."
2025-08-04,Janus Henderson Global Life Sciences Fund Q2 2025 Commentary,SeekingAlpha,Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.
2025-08-05,Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary,SeekingAlpha,Janus Henderson Global Life Sciences Diversified ADR Managed Account returned -3.68% (gross) and the MSCI World Health Care Index returned -3.96%. Read more here.
2025-08-05,QuidelOrtho Corporation (QDEL): A Bull Case Theory,Yahoo,"We came across a bullish thesis on QuidelOrtho Corporation on Valueinvestorsclub.com by Novana. In this article, we will summarize the bulls’ thesis on QDEL. QuidelOrtho Corporation’s share was trading at $27.39 as of July 25th. QDEL’s trailing and forward P/E were 9.16 and 11.22, respectively according to Yahoo Finance. QuidelOrtho (“Quidel”) represents a structurally growing diagnostics franchise […]"
2025-08-06,Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?,Yahoo,"ABT's Diabetes Care sales surge 19.6% in Q2, fueled by strong U.S. demand and new OTC approvals for its CGM systems."
2025-08-06,Abbott Laboratories' (NYSE:ABT) Earnings Are Of Questionable Quality,Yahoo,"Investors were disappointed with Abbott Laboratories' ( NYSE:ABT ) earnings, despite the strong profit numbers. Our..."
2025-08-06,Auxier Asset Management Summer 2025 Market Commentary,SeekingAlpha,"Markets have been a rollercoaster for investors in 2025, with every major benchmark starting the year down in the first quarter to all being up for the second quarter and year-to-date."
2025-08-06,Medical Devices & Supplies - Diversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT),Yahoo,"Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Abbott Laboratories (NYSE:ABT) and its peers."
2025-08-07,"Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma",Yahoo,"The global influenza vaccine market is on a growth trajectory, driven by heightened awareness about vaccination's role in preventing contagious diseases like influenza. In light of recent pandemics, flu vaccination demand is surging, projected to climb from USD 8.96 billion in 2024 to USD 13.32 billion by 2030, at a CAGR of 7%. Rising geriatric populations, government support, and public health campaigns fuel this expansion. Dominant market segments include quadrivalent vaccines, inactivated typ"
2025-08-07,Inside Dexcom’s strategy to stay ahead in the $13.6bn CGM market,Yahoo,"With a new CEO taking over in 2026, Dexcom aims to stay ahead of its CGM competitors through a combination of innovation and product market expansion."
2025-08-07,Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance,Yahoo,"SAN DIEGO, August 06, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025 guidance."
2025-08-07,"Senseonics Holdings, Inc. Reports Second Quarter Financial Results",Yahoo,"Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the second quarter ended June 30, 2025. Recent"
2025-08-08,Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock,Yahoo,"Abbott outpaces market trends as EPD sales surge, fueled by double-digit growth, biosimilar approvals and strong product demand."
2025-08-08,Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?,Yahoo,"HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds."
2025-08-08,Gauzy Ltd. Announces Board of Directors Changes Following Annual Meeting,Yahoo,"Gauzy Pleased to Announce Alejandro Weinstein, Former Director in Gauzy, Elected to Board; A Long-Time Investor and Shareholder Engaged with the Company Since 2016 Gauzy Adopts Leaner Board to Reduce Corporate Expenses and Maintain Agility TEL AVIV, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced changes to its Board of Directors following the Company's annual general meeting"
2025-08-08,Mairs & Power Balanced Fund Q2 2025 Commentary,SeekingAlpha,The Fund underperformed its benchmark by 2.77% due to equity underperformance. Click here to read more.
2025-08-09,3 Stocks Retirees Should Absolutely Love,Yahoo,These stocks check off all the boxes for investors no longer receiving a paycheck.
2025-08-09,Abbott Laboratories Q2 Earnings: Dividends Don't Lie,SeekingAlpha,"Abbottâs Q2 showed resilience amid macro risks, with its dividend strength and fair valuation reinforcing long-term appeal. See why ABT stock is a buy."
2025-08-09,"Dividend Champion, Contender, And Challenger Highlights: Week Of August 10",SeekingAlpha,"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list for the week of August 10, 2025 -- here on Seeking Alpha."
2025-08-10,"Abbott Laboratories (NYSE:ABT) jumps 5.5% this week, though earnings growth is still tracking behind five-year shareholder returns",Yahoo,"If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see..."
2025-08-11,SetPoint Medical secures $140M to fund neuromodulation for arthritis,Yahoo,"Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month."
2025-08-11,Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink?,Yahoo,"As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects."
2025-08-12,"United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK",Yahoo,"The United States Epilepsy Drugs Market is projected to grow from US$ 2.36 billion in 2024 to US$ 3.45 billion by 2033, marking a CAGR of 4.31% from 2025 to 2033. This growth is fueled by the rising prevalence of epilepsy, affecting over 3.4 million Americans, and advancements in drug development. Key players like Eisai, UCB, and Lundbeck emphasize second and third-generation AEDs offering improved safety and efficacy. Despite challenges like high treatment costs and regulatory hurdles, the mark"
2025-08-12,"US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche",Yahoo,"The United States Personalized Medicine Market is projected to soar to US$ 307.04 billion by 2033 from US$ 169.56 billion in 2024, experiencing a CAGR of 6.82% from 2025 to 2033. Key growth drivers include advances in next-generation sequencing, rising demand for customized treatments, and government policy support. The integration of technologies like AI and machine learning is enhancing precision in diagnostics and treatment, revolutionizing personalized healthcare. Market challenges include h"
2025-08-12,"STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories",Yahoo,"The STD Diagnostic Market is projected to reach $17.93 billion by 2033, growing from $9.82 billion in 2024 at a CAGR of 6.92% during 2025-2033. Key growth drivers include increased STD prevalence, technological advancements in diagnostics, and enhanced accessibility to healthcare. Government initiatives and improved public awareness also bolster the market. Segments analyzed include products, testing types, and global regions, emphasizing the demand for point-of-care testing and at-home kits. Si"
2025-08-12,"US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",Yahoo,"The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure"
2025-08-12,Abbott Laboratories shows growth in core products amid market shifts,Yahoo,"Abbott delivered a strong H1 2025, with its US medical device sales growing by 14.8% compared to H1 2024."
2025-08-13,"Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi",Yahoo,"The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Vision 2030, alongside rising chronic diseases and an aging population demanding precise diagnostics. Technological advancements in automation, AI integration, and point-of-care testing further enhance accessibility, especially in underserved areas. With increasing involvement fr"
2025-08-13,"Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk",Yahoo,"The Saudi Arabia Blood Glucose Device Market is anticipated to grow from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, exhibiting a CAGR of 6.78% from 2025-2033. This growth is fueled by rising diabetes incidence, increased health awareness, and government initiatives supporting early diagnosis and self-monitoring. Advances in Continuous Glucose Monitoring (CGM) systems and user-friendly glucometers enhance patient compliance. Key market players include Abbott Laboratories, Medtronic,"
2025-08-13,MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy?,Yahoo,"Medtronic trades at a notable discount to peers as Q1 earnings loom, but rising costs and tariffs could test its resilience."
2025-08-13,5 Must-Read Analyst Questions From Global Business Travel’s Q2 Earnings Call,Yahoo,"Global Business Travel’s second quarter results were met with a strong market reaction, as the company delivered revenue in line with Wall Street expectations despite flat year-on-year sales. Management attributed this outcome to a rebound in corporate travel demand in May and June after a weak April, as well as ongoing efficiency gains and cost controls. CEO Paul Abbott highlighted that the company’s focus on operating leverage and efficiency allowed for margin expansion, even as macroeconomic"
2025-08-14,"HIV Diagnostics Company Evaluation Report 2025 | Abbott, Siemens Healthineers, and Thermo Fisher Scientific Lead the Market with Innovative Portfolios and Strategic Expansion",Yahoo,"The HIV Diagnostics Companies Quadrant report offers an in-depth analysis of the global HIV diagnostics market, assessing over 100 companies and highlighting the Top 14 leaders. Market expansion is driven by rising HIV/AIDS prevalence, point-of-care technological advancements, and awareness campaigns. However, high costs and skilled technician shortages hinder growth. North America leads in market dominance due to its HIV/AIDS prevalence and advanced technologies, while Asia Pacific is projected"
2025-08-14,Abbott Taps Growing TMVR Market With Tendyne System,Yahoo,"ABT wins FDA nod for its Tendyne TMVR system, offering a minimally invasive option for patients with severe mitral valve disease."
2025-08-14,Does Abbott Laboratories (NYSE:ABT) Deserve A Spot On Your Watchlist?,Yahoo,"For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to..."
2025-08-15,Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data,Yahoo,"TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access."
2025-08-15,1 Healthcare Stock for Long-Term Investors and 2 We Ignore,Yahoo,"Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 7.7%. This drop is a noticeable divergence from the S&P 500’s 5.5% return."
2025-08-16,"THQ: 13.3% Top Contrarian Healthcare Yield, Discounted Price",SeekingAlpha,abrdn Healthcare Opportunities Fund offers a compelling way to play the healthcare sector. Read here for an analysis of THQ CEF.
2025-08-18,"Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season",Yahoo,Abbott (NYSE: ABT) and the Big Ten Conference are back with Year 2 of their college rivalry-inspired blood donation competition that leverages the fandom of collegiate athletics to address one of the country's most pressing health crises.
2025-08-18,Abbott Gains in Nutrition With Adult Segment Leading Growth,Yahoo,ABT Nutrition unit posts steady gains as adult-focused brands like Ensure and Glucerna drive global demand and market share growth.
2025-08-18,Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt,Yahoo,"Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that..."
2025-08-18,"If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today",Yahoo,You'd be sitting pretty right now.
2025-08-19,Bank On Healthcare And An Aging Population With 14% Yield: HQH,SeekingAlpha,Discover how rising healthcare spending can be turned into income growth. Build a retirement portfolio that thrives in a key sector.
2025-08-20,DexCom Expands Access and Innovation While Balancing Headwinds,Yahoo,"DXCM grows on type 2 access, Stelo adoption, and new sensor launches, but faces margin pressures, competition and leadership transition."
2025-08-20,"GEHC Positioned for Growth With AI, Global Expansion and Margins",Yahoo,"GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand."
2025-08-20,Should You Invest in Abbott (ABT) Based on Bullish Wall Street Views?,Yahoo,"Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?"
2025-08-20,Q2 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks,Yahoo,"Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its peers."
2025-08-21,2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer,Yahoo,These high-yield dividend stocks are built to last.
2025-08-21,"The Zacks Analyst Blog Highlights Amazon.com, Salesforce, Abbott Laboratories and Fossil Group",Yahoo,"Amazon, Salesforce, Abbott and Fossil Group show diverging trends as AI spending weighs on margins, healthcare pipelines expand, and retail turnarounds gain traction."
2025-08-21,"Top Research Reports for Amazon.com, Salesforce & Abbott",Yahoo,"Amazon posts strong Q2 gains across AWS, Prime and ads, but weak Q3 income guidance and AI costs drag shares lower."
2025-08-21,Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2025 Update,SeekingAlpha,"GMOâs 13F portfolio grew to $33.23B in Q2 2025, with Microsoft, Meta, Alphabet, Oracle, and Apple as top holdings. Read more about the portfolio here."
2025-08-22,Boston Scientific (BSX) Down 0.9% Since Last Earnings Report: Can It Rebound?,Yahoo,Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2025-08-22,"With 80% institutional ownership, Abbott Laboratories (NYSE:ABT) is a favorite amongst the big guns",Yahoo,Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...
2025-08-22,"Homecare Clinical Nutrition Market Report 2025 | Nestle, Abbott, and Danone are Leading the Way in Offering Disease-specific Products for Renal Health, Oncology, Diabetes, and Malabsorption Syndromes",Yahoo,"Growth in the Homecare Clinical Nutrition Market is driven by aging populations, rising chronic diseases, and government initiatives for cost-effective healthcare. HCN products help manage malnutrition, enhance recovery, and reduce hospital readmissions. The market is segmented into oral, enteral, and parenteral routes, with the oral segment leading. Noteworthy trends include personalized nutrition solutions and increased demand for plant-based formulations. Key players include Abbott, Danone, a"
2025-08-23,3 Unstoppable Dividend Stocks to Buy Right Now,Yahoo,Investors will get great dividends and more with these stocks.
2025-08-25,"If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?",Yahoo,"Abbott Laboratories (NYSE:ABT) is a global healthcare company that develops and sells a wide range of health technologies and products. It is set to report its Q3 2025 earnings on Oct. 15. Wall Street analysts expect the company to post EPS of $1.30, ..."
2025-08-25,"Enteral Nutrition Market Focused Insights Report 2025-2030 with Exclusive Data on 16 Vendors Including Abbott, B. Braun, Danone, Nestle, Fresenius Kabi",Yahoo,"The global enteral nutrition market is projected to grow at a CAGR of 6.78% from 2024 to 2030, driven by a rise in cancer and neurological diseases. Key market players, including Danone and Nutrisens Group, are expanding their portfolios through strategic acquisitions in Latin America and the U.S. The tube-feeding segment leads with 57% of the market share, especially in APAC, the dominant region. Driving factors include a shift from parenteral to enteral nutrition and innovations in feeding tec"
2025-08-25,Best Dividend Kings: August 2025,SeekingAlpha,Dividend Kings underperformed SPY year-to-date but are showing stronger gains in August. Learn more about the Dividend Kings here.
2025-08-26,Is Abbott Laboratories' (NYSE:ABT) Stock's Recent Performance A Reflection Of Its Financial Health?,Yahoo,Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 4.2% over the past month. Since...
2025-08-26,Abbott’s Esprit BTK System gains CE mark for PAD treatment,Yahoo,"The stent is engineered to keep arteries open, deliver everolimus for vessel healing, and gradually dissolve over time."
2025-08-26,"Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment",Yahoo,"Abbott (NYSE: ABT), the global healthcare leader, has received regulatory approval for the first denosumab biosimilar in Thailand, expanding access to advanced therapies for osteoporosis and cancer-related bone loss. With the introduction of Abbott's denosumab biosimilar in Thailand, this advanced biologic treatment will be more affordable and accessible for the estimated 3 million people suffering from osteoporosis and bone-disease related illness in the country.1,2,3"
2025-08-27,"ASEAN Point of Care Diagnostics Company Evaluation Report 2025 | Abbott, Roche, and Siemens Healthineers Lead with Leadership in Diagnostics, Personalized Care, and AI-Integrated Medical Technologies",Yahoo,"The ASEAN Point of Care Diagnostics Companies Quadrant is an essential industry analysis providing insights into the ASEAN market. The '360 Quadrants' evaluated over 62 companies, identifying the Top 15 in diagnostics as quadrant leaders. The assessment prioritized criteria such as revenue, geographic presence, and product innovation, focusing on categories like glucose monitoring and cardiovascular testing. Key players in the market include Abbott, F. Hoffmann-La Roche, and Siemens Healthineers"
2025-08-27,Best Dividend Aristocrats For September 2025,SeekingAlpha,"Discover top Dividend Aristocrats for 2025! Explore undervalued picks with 10%+ annualized returns, robust payout growth, and reliable income opportunities."
2025-08-27,NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings,Yahoo,The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
2025-08-27,What's Driving Abbott's Gross Margin Growth Amid Macro Issues,Yahoo,"ABT's gross margin hits 56.4% in Q2, fueled by Medical Devices growth, Nutrition strength, FX tailwinds and cost discipline."
2025-08-27,BIGY: Targeted 12% Distribution With Options Strategy,SeekingAlpha,Read the latest analysis on the YieldMax Target 12 Big 50 Option Income ETF: A diversified large-cap covered call strategy targeting a 12% yield.
2025-08-28,"MedTech Healthcare IT Industry Competitive Landscape Analysis Report 2025 Featuring Medtronic, Abbott, Johnson & Johnson Services Inc., Siemens Healthineers AG, Oracle Health and Optum",Yahoo,"Explore the latest insights on the global MedTech and healthcare IT market. This report covers top companies, innovative technologies, and regulatory updates across the U.S., Europe, and Japan. Discover market trends and competitive landscapes in medical devices, IVD, and healthcare IT industries.Dublin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The ""MedTech Healthcare IT Industry Competitive Landscape"" report has been added to ResearchAndMarkets.com's offering.This research report analyzes the global m"
2025-08-28,2 Reasons to Watch ABT and 1 to Stay Cautious,Yahoo,"Abbott Laboratories currently trades at $131.61 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 8.8% gain during that period."
2025-08-28,"Abbott Laboratories CEO warns tariffs are here to stay, points to new US investments",Yahoo,CEO Robert Ford says Abbott is investing in US manufacturing and supply chains to navigate rising global tensions
2025-08-28,Abbott Labs CEO on tariff hits & big US manufacturing investment,Yahoo,"Frustration is growing around the rising cost of tariffs, and some companies are responding with big bets on US production. Abbott (ABT) CEO Robert Ford joins Yahoo Finance Executive Editor Brian Sozzi on Market Catalysts to discuss the company's new US manufacturing investments, including $500 million going into plants in Illinois and Texas. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts."
2025-08-29,ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?,Yahoo,"As the structural heart market expands, Abbott and Edwards battle for leadership. Which stock holds stronger growth momentum now?"
2025-08-29,Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis,Yahoo,"Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for an expanded indication for the company's Navitor™ transcatheter aortic valve implantation (TAVI) system to treat people with symptomatic, severe aortic stenosis who are at low or intermediate risk for open-heart surgery. Abbott previously received CE Mark in 2021 for Navitor to treat people with symptomatic, severe aortic stenosis who are at high or extreme surgical risk. With this new approval, Navitor is available in Euro"
2025-08-29,The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice,SeekingAlpha,"Discover why Avanos Medical, Inc. offers a compelling turnaround investment. Click for more on AVNS stock and why I think it is a bargain."
2025-08-29,Cirtec Medical Announces Appointment of New Chief Executive Officer,Yahoo,"BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025. Shar brings more than 25 years of global leadership experience in the medical technology sector, with a proven track record of scaling businesses, driving innovation, and building strong custom"
2025-08-30,Sector Update: Health Care Stocks Higher Late Afternoon,Yahoo,Health care stocks rose late Friday afternoon with the NYSE Health Care Index and the Health Care Se
2025-08-31,Abbott’s Possible Pokeno Acquisition Might Change the Case for Investing in Abbott Laboratories (ABT),Yahoo,"In August 2025, it was reported that Abbott Laboratories was in discussions with Synlait Milk Limited to acquire the Pokeno manufacturing facility in New Zealand, a site specializing in plant-based milk products and recently flagged in Synlait’s business recovery review. This potential deal underscores Abbott’s ongoing diversification beyond core medical devices into nutritional and alternative product categories, as Synlait considers selling the facility amid efforts to address operational..."
2025-09-01,How Is Abbott Laboratories' Stock Performance Compared to Other Medical Devices Stocks?,Yahoo,"Although Abbott Laboratories has underperformed its industry peers recently, analysts remain highly optimistic about the stock’s prospects."
2025-09-01,ABT Stock Gains From Navitor's Expanded Indication Approval in Europe,Yahoo,"Abbott wins CE Mark in Europe for expanded Navitor use, boosting its Structural Heart business and lifting ABT stock."
2025-09-01,"Remote Patient Monitoring (RPM) Market Company Evaluation Report 2025: Philips, Medtronic, and Abbott Dominate with Advanced Devices, Global Reach, and Strategic Innovations",Yahoo,"Discover the Remote Patient Monitoring (RPM) Companies Quadrant—a pivotal analysis of the global RPM market offering insights into key players, technological advancements, and emerging trends. The '360 Quadrants' highlights 21 top companies leading the RPM industry, including Philips, Medtronic, and Abbott. RPM technologies help cut healthcare costs and improve patient outcomes by enabling home-based care. Despite regional regulatory challenges, RPM utilizes wearables and mobile apps to provide"
2025-09-01,Jim Cramer Shares Little Known Potential Catalyst For Abbott Laboratories (ABT),Yahoo,We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT)’s shares have gained 16.7% year-to-date despite suffering from a major dip in July. The shares sank by 8.5% after the firm’s second-quarter earnings failed to satiate growth-hungry […]
2025-09-02,"FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes",Yahoo,"Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes."
2025-09-02,"Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others",Yahoo,"Opportunities in the hemato-oncology testing market include rising lymphoma and myeloma cases, personalized therapy demand, and advanced molecular diagnostics. Emerging technologies like single-cell sequencing and long-read sequencing enhance diagnostic precision, thus driving market growth and improving patient outcomes. Hemato Oncology Testing Market Hemato Oncology Testing Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The ""Hemato-Oncology Testing Market Size, Share & Trends Analysis 2025-"
2025-09-02,Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth,Yahoo,"Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (""Defence"" or the ""Company""), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the engagement of Amie Phinney, PhD, MBA as the Strategy & Business Advisor, effective immediately. Dr. Phinney will work closely with senior leadership to refine and align the company's short- and long-term strategies as it pursues exciting new..."
2025-09-02,Investing in the Age of Longevity: Silver Economy Stocks in Focus,Yahoo,"AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations."
2025-09-03,3 medtech takeaways from ESC 2025,Yahoo,Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.
2025-09-03,"Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe",Yahoo,Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”
2025-09-03,Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment,Yahoo,"Stephan Crokaert, formerly of NeoMedLight, Abbott, Adagio and Boston Scientific, brings more than 35 years of strategic and commercial experience in life sciencesAllegro prepares to advance lead product hydrocelin into clinical trials in 2026 Liege, Belgium – 3 September 2025 (08:30) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, has appointed Stephan Crokaert into the role of Chief Operating Officer as of this month."
2025-09-03,Medtronic advances Abbott partnership with FDA nod,Yahoo,"The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes."
2025-09-04,Hologic's Panther Fusion Signals More Molecular Diagnostics Upside,Yahoo,"HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing."
2025-09-04,Returns Are Gaining Momentum At Abbott Laboratories (NYSE:ABT),Yahoo,"If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an..."
2025-09-04,Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?,Yahoo,There is more to like than the dividend with these companies.
2025-09-05,MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G,Yahoo,"Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration."
2025-09-07,The BLSH Strategy: The Compounding Machine,SeekingAlpha,"The BLSH strategy uses rules-based signals to buy undervalued blue chips and sell at highs, delivering 14.8% CAGR over 30 years. Learn why this method beats the S&P 500."
2025-09-08,1 Reason Every Investor Should Know About AbbVie (ABBV),Yahoo,This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors.
2025-09-08,"Buy Abbott Laboratories (ABT) If You’re Worried About COVID, Says Jim Cramer",Yahoo,We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is one of the largest pharmaceutical companies in the world. Its shares have gained 17% year-to-date and have recovered all of their losses […]
2025-09-09,"The Zacks Analyst Blog Highlights Broadcom, T-Mobile, Abbott Laboratories, CBL & Associates Properties and Crown Crafts",Yahoo,"Zacks Analyst Blog spotlights Broadcom, T-Mobile, Abbott, CBL & Associates, and Crown Crafts with updates on growth, risks, and outlooks."
2025-09-09,Investing in Abbott Laboratories (NYSE:ABT) five years ago would have delivered you a 37% gain,Yahoo,"When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than..."
2025-09-09,"Top Research Reports for Broadcom, T-Mobile & Abbott",Yahoo,"Broadcom, T-Mobile, and Abbott lead Zacks Research Daily with AI gains, 5G leadership, and strong medical device pipelines driving momentum."
2025-09-10,MedtechWOMEN Announces Virginia L. Giddings as Winner of the 2025 Ferolyn Powell Award,Yahoo,"MENLO PARK, Calif., September 10, 2025--MedtechWOMEN today announced that Virginia Giddings, Ph.D., vice president of Exploration at Edwards Lifesciences, has been named the recipient of the 2025 Ferolyn Powell Leadership Award, honoring her extraordinary contributions to advancing healthcare innovation, mentoring the next generation of leaders, and fostering diversity in the medical technology industry."
2025-09-10,Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller,Yahoo,"Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher. On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing its integration with Abbott’s Instinct sensor for type 1 diabetes. At the same time, the company’s […]"
2025-09-11,Abbott (ABT) Stock Sinks As Market Gains: What You Should Know,Yahoo,"Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close."
2025-09-11,NVST vs. ABT: Which Stock Should Value Investors Buy Now?,Yahoo,NVST vs. ABT: Which Stock Is the Better Value Option?
2025-09-12,"Encephalopathy Market Worth $209 Million in 2025 Led by Salix Pharma, Abbott Labs, and Fresenius Kabi: Analysis of Key Trends & Strategies",Yahoo,"The encephalopathy market offers opportunities in early intervention, advanced diagnostics, and multidisciplinary care. Growth is driven by digital therapeutics, patient-centric models, telemedicine, and regional adaptation. Strategic partnerships, personalized care, and supply chain resilience are critical for success. Encephalopathy Market Encephalopathy Market Dublin, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The ""Encephalopathy Market - Global Forecast 2025-2030"" report has been added to ResearchAn"
2025-09-13,Is Now The Time To Put Abbott Laboratories (NYSE:ABT) On Your Watchlist?,Yahoo,"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story..."
2025-09-13,3 No-Brainer Dividend Stocks to Buy in September,Yahoo,The attraction of these dividend stocks isn't limited to their dividends.
2025-09-15,"US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",Yahoo,"The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from US$ 2 billion in 2024, reflecting a CAGR of 7.11% from 2025 to 2033. This growth is driven by increasing substance misuse, stringent workplace regulations, technological advancements, government support, and rising public awareness. The sector is essential in tackling drug-related challenges through innovative testing methods such as urine, saliva, hair, and blood analyses,"
2025-09-16,Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?,Yahoo,"The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?"
2025-09-17,Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?,Yahoo,"Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously..."
2025-09-17,Abbott (ABT) Gains As Market Dips: What You Should Know,Yahoo,"Abbott (ABT) concluded the recent trading session at $132.76, signifying a +1.09% move from its prior day's close."
2025-09-18,Is it the Right Time to Retain Abbott Stock in Your Portfolio?,Yahoo,"ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook."
2025-09-18,Hologic's Strong International Traction to Continue Despite Headwinds,Yahoo,"HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges."
2025-09-18,"AI in Remote Patient Monitoring Market Projected to Reach US$ 10.35 Billion by 2033, Expanding at 6.7% CAGR, According to DataM Intelligence",Yahoo,"According to DataM Intelligence, the global AI in remote patient monitoring market reached US$ 5.45 billion in 2023, with a rise to US$ 5.78 billion in 2024, and is expected to reach US$ 10.35 billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025–2033."
2025-09-19,"Smart Medical Devices Market Size to Reach $180.4 Billion by 2033 - Strategic Growth Opportunities in Chronic Disease Management, Digital Health, and Connected Care",Yahoo,"The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence."
2025-09-19,Abbott Declares 407th Consecutive Quarterly Dividend,Yahoo,The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
2025-09-19,1 Dividend King To Hold And 2 Worth Buying Now,SeekingAlpha,"It's often said that cash is king, but I would take it one step further."
2025-09-19,Transcatheter mitral valve implantation market to display considerable growth,Yahoo,"The TMVI market is set to grow due to an ageing population increasing the prevalence of mitral regurgitation, among other factors."
2025-09-19,FDA posts early alert about Abbott’s Tactiflex Ablation Catheter,Yahoo,Catheter tips came off three damaged devices during surgery but none of the patients suffered serious injuries or died.
2025-09-20,Pivot Bio CEO to Spotlight the Commercial Opportunity of Sustainability and Innovation in Agriculture at Climate Week NYC,Yahoo,"Pivot Bio, one of the world's most innovative agtech companies, will take center stage during Climate Week in New York City (Sept. 22–24). CEO Chris Abbott will join global business and sustainability leaders to highlight how agriculture is advancing climate solutions, reducing costs and strengthening the economic resilience of rural communities."
2025-09-20,Abbott warns of package-induced damage of ablation catheters,Yahoo,"While there have been no injuries as of yet, the FDA said it is monitoring this “potentially high-risk issue.”"
2025-09-21,Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 81% of the company,Yahoo,Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...
2025-09-21,Dividend Paying Stocks With Stability: AbbVie’s (ABBV) Consistent Record,Yahoo,AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Dividend Paying Stocks to Buy Now. AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company that was spun off from Abbott Laboratories in 2013 and is worth considering for a long-term portfolio. One of the strongest reasons to invest in the company is its dividend. The company’s recent […]
2025-09-22,Jim Cramer on Baxter: “They Are the King of Disappointment”,Yahoo,"Baxter International Inc. (NYSE:BAX) is one of the stocks Jim Cramer recently gave takes on. A caller asked whether they should continue to hold or sell the stock, and Cramer commented: “Oh my god, you know, Baxter, go buy Abbott Labs. I mean, I gotta tell you, Baxter’s been such an incredible disappointment. It’s painful. […]"
2025-09-22,Don't Overlook These 2 Dividend Kings in Today's Volatile Market,Yahoo,"These businesses may be ""boring,"" but that's a good thing in today's market."
2025-09-24,Building Consistent Income in a Dividend Stock Portfolio with Abbott Laboratories (ABT),Yahoo,"Abbott Laboratories (NYSE:ABT) is included among the Best Retirement Stocks for a Dividend Stock Portfolio. Abbott Laboratories (NYSE:ABT) operates a broad business spanning four main areas: medical devices, established pharmaceuticals, diagnostics, and nutrition. With a strong global presence, its diversified structure helps balance performance when one segment experiences weakness. Abbott Laboratories (NYSE:ABT) also sees several […]"
2025-09-24,Best Dividend Kings: September 2025,SeekingAlpha,"Discover which Dividend Kings outperformed the SPY in 2024, top stock picks, growth outlooks, and find undervalued opportunities."
2025-09-24,Abbott Hosts Conference Call for Third-Quarter Earnings,Yahoo,"Abbott (NYSE: ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens."
2025-09-24,"Blood Collection Market Forecast and Competitive Strategy Report 2025-2033: Abbott, BD, Roche and Siemens Healthineers Lead as Global Players Drive Innovation and Integrated Solutions",Yahoo,"The blood collection market offers growth opportunities driven by increased demand for automated systems, expanding diagnostic and treatment applications, and personalized medicine. Key regions include North America, Europe, and emerging Asia-Pacific markets, supported by advancements in technologies and healthcare infrastructure improvements.Dublin, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The ""Blood Collection Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Play"
2025-09-24,These Dividend Stocks Have Big Yields and Are Beating the Odds,Yahoo,"Income is lagging growth this year. But companies like Seagate, Newmont, Tapestry and CVS offer the best of both worlds: solid dividend yields and strong stock performance."
2025-09-25,Tia Health and Molecular Testing Labs Partner to Launch the First-Ever FDA-Cleared Home-Collected 4-Plex STI Test,Yahoo,"Tia Health (Tia), the modern women's healthcare platform, and Molecular Testing Labs (MTL), a leader in high-throughput and high-complexity clinical laboratory diagnostics, have partnered to offer to Tia's patients virtually and in clinics around the country the first FDA-cleared home-collection kit* that simultaneously detects four common sexually transmitted infections (STIs)."
2025-09-25,"Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnership",Yahoo,"Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in becoming a standalone firm."
2025-09-25,WeRide Named to Fortune's 2025 Change the World List for Its Leading Role in Driving Social Impact with Autonomous Mobility,Yahoo,"The company was also included in Fortune's 2025 Future 50 List for demonstrating strong long-term growth potentialNEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, has been named to Fortune's Change the World list for 2025 as the only autonomous vehicle (AV) tech company. This marks WeRide's second appearance on the list, following its debut at No. 8 in 2023, joining companies such as Abbott Laboratories, Alibaba, and Schneider E"
2025-09-25,1 Unpopular Stock That Deserves Some Love and 2 We Avoid,Yahoo,"When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory."
2025-09-25,Here's Why Abbott (ABT) Fell More Than Broader Market,Yahoo,"In the closing of the recent trading day, Abbott (ABT) stood at $133.89, denoting a -1.47% move from the preceding trading day."
2025-09-26,"Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035 | Roche, Abbott, Thermo Fisher, and Illumina Among Key Players Shaping Molecular Diagnostics",Yahoo,"Molecular diagnostics offers rapid testing, crucial for personalized medicine and disease detection. Growth opportunities arise in segments like reagents, NGS technology, and infectious diseases. Expanding markets in Asia, rising preventive healthcare awareness, and strong players boost the industry. Molecular Diagnostics Market by Test Type Molecular Diagnostics Market by Test Type Leading Players Leading Players Molecular Diagnostics Providers Molecular Diagnostics Providers Dublin, Sept. 26,"
2025-09-26,"Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail",Yahoo,ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
2025-09-26,Is Abbott Laboratories' (NYSE:ABT) Recent Performance Tethered To Its Attractive Financial Prospects?,Yahoo,Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 1.3% over the past month. Given...
2025-09-26,US medtech stocks fall as Trump administration opens import probe,Yahoo,"(Reuters) -U.S. medtech stocks fell on Thursday after the U.S. Commerce Department opened a probe into imports of medical devices, pressuring shares across the sector.  Analysts said the investigation may weigh on companies with globally sourced supply chains and create a modest overhang for the stocks.  Companies like GE HealthCare, Becton Dickinson, Stryker, Insulet, Intuitive Surgical and ResMed were among the worst performers on the S&P Health Care Equipment index, down between 4% and 11%."
2025-09-28,Best Dividend Aristocrats For October 2025,SeekingAlpha,"Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now."
2025-09-29,Synlait Milk agrees North Island asset sale to Abbott Laboratories,Yahoo,"The assets, including the Pokeno factory, amount to around half of Synlait’s average market capitalisation."
2025-09-29,Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee,Yahoo,"Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its kind treatment innovation for people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug, everolimus, to support vessel healing prior to completely dissolving."
2025-09-29,What to Expect From Abbott Laboratories' Next Quarterly Earnings Report,Yahoo,"Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth."
2025-09-29,"NZ's Synlait cuts annual loss, inks asset sale deal; shares surge",Yahoo,"(Reuters) -Synlait Milk reported a much narrower annual net loss on Monday and announced the sale of its North Island assets for NZ$307 million ($177.2 million) to U.S.-based Abbott Laboratories, sending its shares surging.  The dairy producer said in a statement that strong customer demand and new product development in the Advanced Nutrition business segment delivered a NZ$21.1 million underlying gross margin increase, while a turnaround from last fiscal year's poor Ingredients business performance also helped the bottom line.  The company announced the divestiture of its North Island assets to healthcare firm Abbott, which is expected to strengthen Synlait’s financial position by significantly reducing debt."
2025-09-30,Abbott Laboratories (ABT): A Healthcare Leader Offering Dividend Value and Growth,Yahoo,"Abbott Laboratories (NYSE:ABT) is included among the 11 Best Value Dividend Stocks to Buy Now. Abbott Laboratories (NYSE:ABT) produces a wide range of healthcare products and medical devices, with its business divided into four main areas: established pharmaceuticals, diagnostics, nutrition, and medical devices. On September 19, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 […]"
2025-10-01,Marla Beck Steps Down as CEO of Hydrafacial Owner,Yahoo,Beck will be succeeded as president and CEO of BeautyHealth by Pedro Malha.
2025-10-01,Here are the October additions to Goldman’s ’U.S. Conviction List - Directors’ Cut,Yahoo,"Investing.com -- Goldman Sachs has updated its U.S. Conviction List – Directors’ Cut for October, adding four new stocks while removing three others."
2025-10-01,"United States Continuous Glucose Monitoring (CGM) Market Forecast 2025-2033: Focus on California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, Washington, New Jersey",Yahoo,"The United States Continuous Glucose Monitoring (CGM) Market is projected to surge from US$ 2.05 billion in 2024 to US$ 4.23 billion by 2033, growing at a CAGR of 8.36% from 2025-2033. Key growth drivers include the rising prevalence of diabetes, technological advancements, enhanced insurance coverage, and increased awareness. Major players like Dexcom, Abbott, and Medtronic lead the market with user-friendly, accurate devices. The integration of CGMs is pivotal for proactive diabetes management"
2025-10-01,"Defensive stocks show deep value as cyclicals run hot, UBS says",Yahoo,Investing.com-- Defensive plays like healthcare equipment and benchmark pharma now offer deeper value at a time when cyclical sectors are trading at historically expensive levels and are pricing in a sharp earnings reboundd despite cooling domestic demand in the US and stuttering Eurozone growth.
2025-10-01,Beauty Health Names Pedro Malha as CEO,MarketWatch,Beauty Health Names Pedro Malha as CEO
2025-10-02,"North America Precision Nutrition Market Analysis Report 2025-2032: Abbott, Dexcom, Nestle and DSM Lead Ecosystem Expansion with Integrated Diagnostics and Supplements",Yahoo,"The North American precision nutrition market offers significant growth opportunities driven by U.S. dominance, burgeoning Canadian and Mexican markets, technological integration, and personalized solutions. Key areas include personalized plans, genomic services, direct-to-consumer models, and partnerships in biomarker and AI-driven innovations. north-america-precision-nutrition-market-size-segmentation.jpg north-america-precision-nutrition-market-size-segmentation.jpg north-america-precision-nu"
2025-10-02,Boston Scientific aims for market leadership in electrophysiology,Yahoo,"The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth."
2025-10-02,Abbott Laboratories (ABT) Maintains Strong MedTech Growth Outlook,Yahoo,"Abbott Laboratories (NYSE:ABT) ranks among the top picks for a retirement portfolio. UBS maintained Abbott Laboratories (NYSE:ABT) as a top choice in the Medical Supplies and Devices industry on September 23, reaffirming its Buy rating on the company’ shares with a price target of $154. The firm expressed strong confidence in the company’s future trajectory, […]"
2025-10-02,2 Profitable Stocks to Consider Right Now and 1 We Find Risky,Yahoo,"While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, ""Your margin is my opportunity""."
2025-10-02,Abbott Gains Diabetes Tech Expansion Opportunity Following Earnings Beat and Insider Sale,Yahoo,"Abbott Laboratories (NYSE:ABT) is one of the 12 Set-It-and-Forget-It Stocks to Buy Now. Amid a positive second quarter and a top executive sale, the company gains an expansion opportunity from Medtronic. Abbott Laboratories (NYSE:ABT) reported a 6.9% increase in sales for the second quarter of 2025. The earnings report, announced on July 17, 2025, also […]"
2025-10-03,Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?,Yahoo,"The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?"
2025-10-03,Should Health Canada’s Approval of Abbott (ABT) Dissolvable Stent Drive a Rethink for Investors?,Yahoo,"Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind dissolvable stent designed to treat chronic limb threatening ischemia below the knee using a minimally invasive approach. This innovative device not only keeps arteries open and supports vessel healing, but also significantly reduces the need for repeat procedures in a condition with high rates of amputation and mortality. We'll explore how..."
2025-10-03,Medtronic wins CE mark for Penditure LAA exclusion device,Yahoo,"The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product."
2025-10-04,Abbott (ABT) Laps the Stock Market: Here's Why,Yahoo,"Abbott (ABT) reached $134.59 at the closing of the latest trading day, reflecting a +1.2% change compared to its last close."
2025-10-04,"Top Stock Reports for AMD, Abbott & Micron Technology",Yahoo,"AMD, Abbott and Micron shine in fresh Zacks reports, highlighting AI momentum, product pipelines and strong financial positioning."
2025-10-06,"The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories and Micron Technology",Yahoo,"AMD, Abbott and Micron showcase strong momentum as AI demand, medical innovation and memory recovery drive growth prospects."
2025-10-06,DexCom May Be The Most Underrated Growth Story In Healthcare,SeekingAlpha,"DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory risks. Learn why DXCM stock is a buy."
2025-10-07,"Saudi Arabia Liquid Dietary Supplements Market Analysis & Opportunity Report 2025 Featuring Nestle, Abbott, Bayer, Herbalife Nutrition, and NOW Foods",Yahoo,"The Saudi Arabia liquid dietary supplements market is growing due to rising health awareness, preference for preventive care, and demand for convenient liquid formulations. Key opportunities include prenatal and bone & joint supplements, expanded online sales, and tailored nutrition services, despite challenges like high competition and market fragmentation. Saudi Arabian Liquid Dietary Supplements Market Saudi Arabian Liquid Dietary Supplements Market Dublin, Oct. 07, 2025 (GLOBE NEWSWIRE) -- T"
2025-10-07,QuantiPath Appoints Jeff Nauseda as Director of Market Development -- Bolstering Beef & Pet Food Reach Ahead of GenoPATHX Launch,Yahoo,"QuantiPath (quantipath.bio), the biotechnology company advancing genomic pathogen diagnostics for food safety, today announced the appointment of Jeff Nauseda as Director of Market Development, with principal responsibility for scaling QuantiPath's presence in the beef and pet food sectors. This strategic hire strengthens a leadership team that already offers deep coverage in poultry and swine."
2025-10-07,Assessing Abbott (ABT) Valuation Following First Health Canada Approval for Innovative Esprit BTK Dissolvable Stent,Yahoo,"Abbott Laboratories (ABT) just received Health Canada approval for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent designed to treat chronic limb threatening ischemia below the knee. This regulatory milestone is boosting attention on Abbott’s device pipeline and its long-term growth prospects. See our latest analysis for Abbott Laboratories. Abbott’s approval win arrives just as momentum in its medical device business is starting to build again. With shares..."
2025-10-07,Abbott Laboratories' (NYSE:ABT) Returns On Capital Are Heading Higher,Yahoo,"If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for..."
2025-10-07,"US Human Papilloma Virus (HPV) Testing Market Forecast Report 2025-2033: California, Texas, New York, and Florida Lead Through Innovation, Accessibility, and Preventive Healthcare Initiatives",Yahoo,"The U.S. Human Papilloma Virus (HPV) testing market is poised for significant growth, projected to reach $1.01 billion by 2033 from $457.52 million in 2024 with a 9.24% CAGR. Key drivers include rising cervical cancer awareness, expanded screening programs, and technological advancements. Regulatory approvals, like Abbott's Alinity m HR HPV assay and Roche's Cobas test, enhance diagnostic options. Increasing self-sampling access and public-private partnerships support underserved populations. Ch"
2025-10-07,3 Dividend Stocks to Double Up On Right Now,Yahoo,The time is right for buying more of these great dividend stocks.
2025-10-08,"Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",Yahoo,"The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a"
2025-10-08,Abbott Laboratories (ABT): A Healthcare Leader Powering the List of Profitable Dividend Stocks,Yahoo,"Abbot⁠t Labor‌atories (NYSE​:ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Abbot⁠t Labor‌atories (NYSE​:ABT) has lo‌ng⁠ been a household name in the healthc‌are w‍o‌rl‍d, offering pr‌o‍ducts th​at reach milli‍o‌n‌s of people​ every day. Its operations span several major areas, includ‌ing pre⁠scription medici⁠nes⁠, med‌ical devices, d‍iagnostics, and nu‍trition.⁠ The compa‍ny’s portfolio […]"
2025-10-08,2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid,Yahoo,"A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand."
2025-10-09,Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview),SeekingAlpha,"Abbott Laboratories is set to report Q3 earnings, with EPS expectations of $1.30, reflecting 8.3% YoY growth. Learn more about ABT stock here."
2025-10-09,How pharma giant AbbVie holds leaders accountable for culture,Yahoo,The pharmaceutical company is one of the honorees on the Fortune 100 Best Companies to Work For Europe list in 2025.
2025-10-09,"Abbott Laboratories Still Offers Attractive Valuation, UBS Says",Yahoo,"Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl"
2025-10-10,"Align downgraded, NetEase upgraded: Wall Street's top analyst calls",Yahoo,"Align downgraded, NetEase upgraded: Wall Street's top analyst calls"
2025-10-10,Wall Street's Insights Into Key Metrics Ahead of Abbott (ABT) Q3 Earnings,Yahoo,"Evaluate the expected performance of Abbott (ABT) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight."
2025-10-10,Abbott to Report Q3 Earnings: Medical Devices Arm in Focus,Yahoo,"ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics."
2025-10-10,Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors,Yahoo,"Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) (""Therma"" or the ""Company""), a developer and investment partner in advanced diagnostic and medical device technologies, is pleased to announce the appointment of Michael Raimondo, a 30-year veteran in sales and operations in the healthcare industry to its Board of Directors. Michael was part of Therma's advisory Board, previously announced on August 13, 2024.Mr. Raimondo is a..."
2025-10-11,Those who invested in Abbott Laboratories (NYSE:ABT) three years ago are up 39%,Yahoo,"Low-cost index funds make it easy to achieve average market returns. But in any diversified portfolio of stocks, you'll..."
2025-10-11,"JPMorgan, Goldman Sachs Among Big Banks Set To Report Earnings Next Week",SeekingAlpha,Next week will witness a slew of earnings from banking giants. Investors will keep a close eye on economic reports that will be released next week. See more.
2025-10-11,"Dividend Champion, Contender, And Challenger Highlights: Week Of October 12",SeekingAlpha,"Read here for the latest weekly summary of dividend changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers."
2025-10-11,Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.,Yahoo,"Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, the weak have failed, rates are falling, and M&A looks to be on the upswing."
2025-10-11,"Abbott is a steady Medtech company in an unsteady world, says Benchmark",Yahoo,"Investing.com -- Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment."
2025-10-12,"Stocks dip as government shutdown continues, rare earths rally: What to watch this week",Yahoo,The stock market will enter the second full week of the government shutdown. Investors will also focus on big bank earnings.
2025-10-12,"What to Expect in Markets This Week: Big Bank Earnings, Fed Speakers, Shutdown Data Delays",Yahoo,"Coming up: reports from JPMorgan and other big banks, a bond market holiday, shutdown-related data delays, and remarks from top Fed and government officials."
2025-10-12,Wall Street Week Ahead,SeekingAlpha,"Get the latest on Q3 earnings, U.S.-China trade tensions, and top income investment tips."
